EurekaMag Full Text Articles Chapter 49,842

Christensen, S. 2004: PCR analysis. Australian Family Physician 33(9): 679

Cuccuru, M.Antonietta.; Cottoni, F.; Fiori, P.Luigi.; Masala, M.Vittoria.; Cerimele, D. 2005: PCR analysis of Mycoplasma fermentans and M. penetrans in classic Kaposi's sarcoma. Acta Dermato-Venereologica 85(5): 459-460

Kamiya, A.; Kikuchi, A.; Tomita, Y.; Kanbe, T. 2004: PCR and PCR-RFLP techniques targeting the DNA topoisomerase Ii gene for rapid clinical diagnosis of the etiologic agent of dermatophytosis. Journal of Dermatological Science 34(1): 35-48

Li, F.-J.; Gasser, R.B.; Lai, D.-H.; Claes, F.; Zhu, X.-Q.; Lun, Z.-R. 2007: PCR approach for the detection of Trypanosoma brucei and T. equiperdum and their differentiation from T. evansi based on maxicircle kinetoplast DNA. Molecular and Cellular Probes 21(1): 1-7

Yonekawa, H. 2005: PCR as a double-edged sword: ancient DNA and forensic science. Tanpakushitsu Kakusan Koso. Protein Nucleic Acid Enzyme 50(14 Suppl): 1912-1916

Cabrera, O.L.; Munstermann, L.E.; Cárdenas, Río.; Ferro, C. 2003: PCR as a tool in confirming the experimental transmission of Leishmania chagasi to hamsters by Lutzomyia longipalpis (Diptera:Psychodidae). Biomedica: revista del Instituto Nacional de Salud 23(2): 239-244

Zasada, A.A. 2004: PCR as an alternative method for detecting toxigenic strains of Corynebacterium diphtheriae. Medycyna Doswiadczalna i Mikrobiologia 56(4): 321-326

Vera-Sempere, F.J.; Rubio, L.; Felipe-Ponce, V.; García, A.; Mayordomo, F.; Sánchez-Plumed, J.; Beneyto, I.; Ramos, D.; Zamora, I.; Simón, J.é 2006: PCR assays for the early detection of BKV infection in 125 Spanish kidney transplant patients. Clinical Transplantation 20(6): 706-711

Reva, O.N.; Poltavskiĭ, A.N. 2005: PCR based identification of strains of endophytic ecotype of Bacillus amyloliquefaciens. Mikrobiolohichnyi Zhurnal 67(4): 14-20

Mishra, A.; Singh, U.S.; Goel, R.; Kumar, A. 2002: PCR based molecular technique for identification and discrimination of quarantined and non-quarantined Tilletia sps. Indian Journal of Experimental Biology 40(10): 1137-1142

Taechowisan, T.; Peberdy, J.F.; Lumyong, S. 2004: PCR cloning and heterologous expression of chitinase gene of endophytic Streptomyces aureofaciens CMUAc130. Journal of General and Applied Microbiology 50(3): 177-182

Zhai, Y.; Fallon, A.M. 2005: PCR cloning of a histone H1 gene from Anopheles stephensi mosquito cells: comparison of the protein sequence with histone H1-like, C-terminal extensions on mosquito ribosomal protein S6. Bmc Genomics 6: 8

Marks, J.D.; Bradbury, A. 2004: PCR cloning of human immunoglobulin genes. Methods in Molecular Biology 248: 117-134

Mutnal, M.B.; Purwar, S.; Metgud, S.C.; Nagmoti, M.B.; Patil, C.S. 2007: PCR confirmation of cutaneous manifestation due to Brucella melitensis. Journal of Medical Microbiology 56(Pt 2): 283-285

De Silva, R.; Karunaratne, K.; Mendis, L.N.; Ramesh, R.; Chow, V.T.K. 2006: PCR detection and typing of human papilloma virus DNA in squamous carcinoma of the cervix in a cohort of Sri Lankan women. Ceylon Medical Journal 51(3): 114-117

Cho, W-S.; Chae, C. 2003: PCR detection of Actinobacillus pleuropneumoniaeapxIV gene in formalin-fixed, paraffin-embedded lung tissues and comparison with in situ hybridization. Letters in Applied Microbiology 37(1): 56-60

Hanieh, H.; Masuda, K.; Metwally, H.; Chalise, J.P.; Mohamed, M.; Nyati, K.K.; Standley, D.M.; Li, S.; Higa, M.; Zaman, M.M.; Kishimoto, T. 2018: Arid5a stabilizes OX40 mRNA in murine CD4+ T cells by recognizing a stem-loop structure in its 3'UTR. European Journal of Immunology 48(4): 593-604

Morgan, U.M.; Thompson, R.C. 1998: PCR detection of cryptosporidium: the way forward?. Parasitology Today 14(6): 241-245

Remmerbach, T.W.; Brinckmann, U.G.; Hemprich, A.; Chekol, M.; Kühndel, K.; Liebert, U.G. 2004: PCR detection of human papillomavirus of the mucosa: comparison between MY09/11 and GP5+/6+ primer sets. Journal of Clinical Virology: the Official Publication of the Pan American Society for Clinical Virology 30(4): 302-308

Wang, Y.; Yu, D.-J.; Kang, L.; Zhang, G.-M.; Jin, X.-Z.; Yang, W.-D.; Huang, P.-Q.; Wu, Q.; Chen, Z.-N.; Chu, C.-C.; Cheng, Y.-H. 2002: PCR detection of transgenic elements in feed raw material. Yi Chuan 24(3): 293-296

Navalpotro, D.; Gimeno, C.ón.; Navarro, D. 2006: PCR detection of viral DNA in serum as an ancillary analysis for the diagnosis of acute mononucleosis-like syndrome due to human cytomegalovirus (HCMV) in immunocompetent patients. Journal of Clinical Virology: the Official Publication of the Pan American Society for Clinical Virology 35(2): 193-196

Benhattar, J.; Gebhard, S. 2004: PCR diagnosis of T-cell lymphoma in paraffin-embedded bone marrow biopsies. Methods in Molecular Medicine 97: 209-216

Khalturin, K.; Kuznetsov, S.; Bosch, T.C.G. 2003: PCR fluorescence differential display. Methods in Molecular Biology 226: 237-244

Ziegler, D.S.; Cohn, R.J.; Sutton, R.; Norris, M.; Duffy, B.J. 2005: PCR for monoclonal gene rearrangements can differentiate infantile acute lymphoblastic leukemia from cytomegalovirus infection. Leukemia Research 29(1): 111-112

Cuny, C.; Witte, W. 2005: PCR for the identification of methicillin-resistant Staphylococcus aureus (MRSA) strains using a single primer pair specific for SCCmec elements and the neighbouring chromosome-borne orfX. Clinical Microbiology and Infection: the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 11(10): 834-837

Solomennyĭ, A.P.; Maksimov, A.I.; Mochalova, T.I. 2004: PCR genotyping of Acinetobacter hospital isolates. Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 6: 26-30

Velasquez, L.Garcia.; Membrive, N.; Membrive, U.; Rodrigues, G.; Reis, Nélio.; Lonardoni, M.Valdrinez.Campana.; Teodoro, U.; Tessmann, I.Parra.Barbosa.; Silveira, Tís.Gomes.Verzignassi. 2006: PCR in the investigation of canine American tegumentary leishmaniasis in northwestern Paraná State, Brazil. Cadernos de Saude Publica 22(3): 571-578

Jin, U.-H.; Cho, S.-H.; Kim, M.-G.; Ha, S.-D.; Kim, K.-S.; Lee, K.-H.; Kim, K.-Y.; Chung, D.H.; Lee, Y.-C.; Kim, C.-H. 2004: PCR method based on the ogdH gene for the detection of Salmonella spp. from chicken meat samples. Journal of Microbiology 42(3): 216-222

Siqueira, J.é F.; Rôças, I.N. 2003: PCR methodology as a valuable tool for identification of endodontic pathogens. Journal of Dentistry 31(5): 333-339

Zhang, C.; Xu, J.; Ma, W.; Zheng, W. 2006: PCR microfluidic devices for DNA amplification. Biotechnology Advances 24(3): 243-284

Carroll, P.; Casimir, D. 2003: PCR patent issues. Methods in Molecular Biology 226: 7-14

Hyndman, D.L.; Mitsuhashi, M. 2003: PCR primer design. Methods in Molecular Biology 226: 81-88

Zhang, X.-n.; He, X.-h.; Li, J.-c. 2005: PCR products with heterozygous mutations containing two types of heteroduplexes. Zhejiang da Xue Xue Bao. Yi Xue Ban 34(5): 417-420

Tarkin, I.S.; Henry, T.J.; Fey, P.I.; Iwen, P.C.; Hinrichs, S.H.; Garvin, K.L. 2003: PCR rapidly detects methicillin-resistant staphylococci periprosthetic infection. Clinical Orthopaedics and Related Research 414: 89-94

Yang, D.-H.; Liang, W.-F.; Xie, Y.-J.; Zhao, N.-F.; Fan, J. 2002: PCR restriction fragment length polymorphism in detection of YMDD variants of viral polymerase in hepatitis B virus patients treated with lamivudine. Hepatobiliary and Pancreatic Diseases International: Hbpd Int 1(2): 232-237

Mori, I.; Yokochi, T.; Koide, N.; Sugiyama, T.; Yoshida, T.; Kimura, Y.; Naiki, H.; Matsubara, R.; Takeuchi, T.; Nishiyama, Y. 2004: PCR search for the herpes simplex virus type 1 genome in brain sections of patients with familial Alzheimer's disease. Journal of Clinical Microbiology 42(2): 936-937

Li, W.; Yang, J.-G.; Ren, F.-X.; Kang, C.-L.; Zhang, S.-Y. 2004: PCR site-directed mutagenesis of long QT syndrome KCNQ1 gene in vitro. Yi Chuan 26(5): 589-593

Tvorogova, M.G.; Gushchin, A.E. 2006: PCR studies in laboratory diagnosis: problems of quality assurance. Klinicheskaia Laboratornaia Diagnostika 12: 38-41

Glukhov, A.I.; Gordeev, S.A.; Al'tshuler, M.L.; Blinkova, L.P.; Bychenko, A.B.; Tentsov, I.I.; Severin, E.S. 2004: PCR system for the detection of the RNA of hepatitis a virus. Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 4: 50-54

Wiengcharoen, J.Toomphong.; Chiabchalard, R.; Sukthana, Y. 2004: PCR technique for detecting Toxoplasma gondii in animal amniotic fluid. Southeast Asian Journal of Tropical Medicine and Public Health 35(4): 792-795

Shibata, N.; Doi, Y.; Yamane, K.; Yagi, T.; Kurokawa, H.; Shibayama, K.; Kato, H.; Kai, K.; Arakawa, Y. 2003: PCR typing of genetic determinants for metallo-beta-lactamases and integrases carried by gram-negative bacteria isolated in Japan, with focus on the class 3 integron. Journal of Clinical Microbiology 41(12): 5407-5413

Cheng, Q-Qun.; Lu, D-Ru. 2005: PCR-RFLP analysis of cytochrome b gene does not support Coilia ectenes taihuensis being a subspecies of Coilia ectenes. Journal of Genetics 84(3): 307-310

Dobrowolska, A.; Staczek, P.ł; Kaszuba, A.; Kozłowska, M. 2006: PCR-RFLP analysis of the dermatophytes isolated from patients in Central Poland. Journal of Dermatological Science 42(1): 71-74

Buyru, N.; Altinisik, J.; Gurel, C.B.; Ulutin, T. 2003: PCR-RFLP detection of PAI-2 variants in myocardial infarction. Clinical and Applied Thrombosis/Hemostasis: Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 9(4): 333-336

Ratcliffe, S.T.; Webb, D.W.; Weinzievr, R.A.; Robertson, H.M. 2003: PCR-RFLP identification of Diptera (Calliphoridae, Muscidae and Sarcophagidae)--a generally applicable method. Journal of Forensic Sciences 48(4): 783-785

Han, M.; Robinson, M.A. 2003: PCR-SSCP analysis of polymorphism: a simple and sensitive method for detecting differences between short segments of DNA. Methods in Molecular Biology 226: 327-334

Liang, C.; Chu, M.-X.; Zhang, J.-H.; Liu, W.-Z.; Fang, L.; Ye, S.-C. 2006: PCR-SSCP polymorphism of FSHbeta gene and its relationship with prolificacy of Jining grey goats. Yi Chuan 28(9): 1071-1077

Van den Bossche, A.; Van Nevel, C.; Herman, L.; Decuypere, J.; De Smet, S.; Dierick, N.; Heyndrickx, M. 2001: PCR-TGGE: a method for fingerprinting the microbial flora in the small intestine of pigs. Mededelingen 66(3b): 359-363

Ikenoue, N.; Kawazu, S-ichiro.; Hatabu, T.; Villacorte, E.A.; Rivera, P.T.; Kano, S. 2002: PCR-amplification, sequencing, and comparison of the var/PfEMP-1 gene from the blood of patients with falciparum malaria in the Philippines. Southeast Asian Journal of Tropical Medicine and Public Health 33(Suppl 3): 8-13

Kurokawa, Y.; Matoba, R.; Nakamori, S.; Takemasa, I.; Nagano, H.; Dono, K.; Umeshita, K.; Sakon, M.; Monden, M.; Kato, K. 2004: PCR-array gene expression profiling of hepatocellular carcinoma. Journal of Experimental and Clinical Cancer Research: Cr 23(1): 135-141

Dong, Y.; Zhang, C.; Gu, L.-h.; Ping, Y.; Zheng, H.-f. 2006: PCR-based STR genotyping of sweat latent fingerprint samples involved in cases. Fa Yi Xue Za Zhi 22(1): 74-75

Sokolova, Y.Y.; McNally, L.R.; Fuxa, J.R. 2003: PCR-based analysis of spores isolated from smears by laser pressure catapult microdissection confirms genetic identity of spore morphotypes of the microsporidian Thelohania solenopsae. Journal of Eukaryotic Microbiology 50 Suppl: 584-585

Bennett, D.és.ée.E.; Mulhall, R.M.; Cafferkey, M.T. 2004: PCR-based assay for detection of Neisseria meningitidis capsular serogroups 29E, X, and Z. Journal of Clinical Microbiology 42(4): 1764-1765

Spilker, T.; Coenye, T.; Vandamme, P.; LiPuma, J.J. 2004: PCR-based assay for differentiation of Pseudomonas aeruginosa from other Pseudomonas species recovered from cystic fibrosis patients. Journal of Clinical Microbiology 42(5): 2074-2079

Zamora, I.; Feldman, J.L.; Marshall, W.F. 2004: PCR-based assay for mating type and diploidy in Chlamydomonas. Biotechniques 37(4): 534-536

Rubin, L.G.; Rizvi, A. 2004: PCR-based assays for detection of Streptococcus pneumoniae serotypes 3, 14, 19F and 23F in respiratory specimens. Journal of Medical Microbiology 53(Part 7): 595-602

Ishiwada, N.; Cao, L.D.; Kohno, Y. 2004: PCR-based capsular serotype determination of Haemophilus influenzae strains recovered from Japanese paediatric patients with invasive infection. Clinical Microbiology and Infection: the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 10(10): 895-898

Weltman, G.; Fossati, M.S.; Correa, C.; Regueira, M.; Mollerach, M. 2005: PCR-based capsular typing of Haemophilus influenzae isolates non-typeable by agglutination. Revista Argentina de Microbiologia 37(4): 199-202

Venkataraman, T.; Dancausse, E.; King, M.L. 2004: PCR-based cloning and differential screening of RNAs from Xenopus primordial germ cells: cloning uniquely expressed RNAs from rare cells. Methods in Molecular Biology 254: 67-78

Yamakoshi, K.; Shimoda, N. 2003: PCR-based cloning of an intronless zebrafish no tail gene. Biochemical and Biophysical Research Communications 306(2): 598-602

Fischer, P.; Wibowo, H.; Pischke, S.; Rückert, P.; Liebau, E.; Ismid, I.S.; Supali, T. 2002: PCR-based detection and identification of the filarial parasite Brugia timori from Alor Island, Indonesia. Annals of Tropical Medicine and Parasitology 96(8): 809-821

Koppens, P.F.J.; Degenhart, H.J. 2003: PCR-based detection of CYP21 deletions. Clinical chemistry 49(9): 1555-6; author reply 1556-7

Panagea, S.; Winstanley, C.; Parsons, Y.N.; Walshaw, M.J.; Ledson, M.J.; Hart, C.A. 2003: PCR-based detection of a cystic fibrosis epidemic strain of Pseudomonas Aeruginosa. Molecular Diagnosis: a Journal Devoted to the Understanding of Human Disease Through the Clinical Application of Molecular Biology 7(3-4): 195-200

Mike Makrigiorgos, G. 2004: PCR-based detection of minority point mutations. Human Mutation 23(5): 406-412

Speel, E.J.M.; Ramaekers, F.C.S.; Hopman, A.H.N. 2003: PCR-based detection of nucleic acids in chromosomes, cells, and tissues: technical considerations on PRINS and in situ PCR and comparison with in situ hybridization. Methods in Molecular Biology 226: 405-424

Torrea, G.; Van de Perre, P.; Ouedraogo, M.; Zougba, A.; Sawadogo, A.; Dingtoumda, B.ït.; Diallo, B.; Defer, M.C.; Sombié, I.; Zanetti, S.; Sechi, L.A. 2005: PCR-based detection of the Mycobacterium tuberculosis complex in urine of HIV-infected and uninfected pulmonary and extrapulmonary tuberculosis patients in Burkina Faso. Journal of Medical Microbiology 54(Part 1): 39-44

Abou, N.; Houwers, D.J.; van Dongen, A.M. 2006: PCR-based detection reveals no causative role for Mycoplasma and Ureaplasma in feline lower urinary tract disease. Veterinary Microbiology 116(1-3): 246-247

Yang, S.; Rothman, R.E. 2004: PCR-based diagnostics for infectious diseases: uses, limitations, and future applications in acute-care settings. Lancet. Infectious Diseases 4(6): 337-348

Buczolits, S.; Hirt, R.; Rosengarten, R.; Busse, H.-J.ür. 2003: PCR-based genetic evidence for occurrence of Helicobacter pylori and novel Helicobacter species in the canine gastric mucosa. Veterinary Microbiology 95(4): 259-270

Kotłowski, R.; Shamputa, I.C.; El Aila, N.A.; Sajduda, A.; Rigouts, L.; van Deun, A.; Portaels, F.ço. 2004: PCR-based genotyping of Mycobacterium tuberculosis with new GC-rich repeated sequences and IS6110 inverted repeats used as primers. Journal of Clinical Microbiology 42(1): 372-377

Futatsugawa, Y.; Kubota, T.; Ishiguro, A.; Suzuki, H.; Ishikawa, H.; Iga, T. 2004: PCR-based haplotype determination to distinguish CYP2B6*1/*7 and *5/*6. Clinical Chemistry 50(8): 1472-1473

Kanbe, T.; Suzuki, Y.; Kamiya, A.; Mochizuki, T.; Fujihiro, M.; Kikuchi, A. 2003: PCR-based identification of common dermatophyte species using primer sets specific for the DNA topoisomerase Ii genes. Journal of Dermatological Science 32(2): 151-161

Huard, R.C.; Lazzarini, L.C.d.O.; Butler, W.R.; van Soolingen, D.; Ho, J.L. 2003: PCR-based method to differentiate the subspecies of the Mycobacterium tuberculosis complex on the basis of genomic deletions. Journal of Clinical Microbiology 41(4): 1637-1650

Mokrousov, I.; Otten, T.; Vyazovaya, A.; Limeschenko, E.; Filipenko, M.L.; Sola, C.; Rastogi, N.; Steklova, L.; Vyshnevskiy, B.; Narvskaya, O. 2003: PCR-based methodology for detecting multidrug-resistant strains of Mycobacterium tuberculosis Beijing family circulating in Russia. European Journal of Clinical Microbiology and Infectious Diseases: Official Publication of the European Society of Clinical Microbiology 22(6): 342-348

Drahovská, H.; Kocíncová, D.; Seman, M.; Turna, J. 2002: PCR-based methods for identification of Enterococcus species. Folia Microbiologica 47(6): 649-653

Pomati, F.; Neilan, B.A. 2004: PCR-based positive hybridization to detect genomic diversity associated with bacterial secondary metabolism. Nucleic Acids Research 32(1): E7

He, C-Fen.; Takao, K. 2004: PCR-based screening BAC library and direct end sequencing of BAC clones. Yi Chuan Xue Bao 31(11): 1262-1267

Stepanova, A.N.; Alonso, J.M. 2006: PCR-based screening for insertional mutants. Methods in Molecular Biology 323: 163-172

Yi, S.-d.; Meng, S.-r.; Cui, Y.-k.; Chen, Z.-m.; Peng, J. 2003: PCR-based site-directed mutagenesis and recombinant expression plasmid construction of a SCN5A mutation (K317N) identified in a Chinese family with Brugada syndrome. Di 1 Jun Yi da Xue Xue Bao 23(11): 1139-1142

Ladetto, M.; Drandi, D.; Compagno, M.; Astolfi, M.; Volpato, F.; Voena, C.; Novarino, A.; Pollio, B.; Addeo, A.; Ricca, I.; Falco, P.; Cavallo, F.; Vallet, S.; Corradini, P.; Pileri, A.; Tamponi, G.; Palumbo, A.; Bertetto, O.; Boccadoro, M.; Tarella, C. 2003: PCR-detectable nonneoplastic Bcl-2/IgH rearrangements are common in normal subjects and cancer patients at diagnosis but rare in subjects treated with chemotherapy. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 21(7): 1398-1403

Papaxanthos-Roche, A.; Trimoulet, P.; Commenges-Ducos, M.; Hocké, C.; Fleury, H.J.A.; Mayer, G. 2004: PCR-detected hepatitis C virus RNA associated with human zona-intact oocytes collected from infected women for ART. Human Reproduction 19(5): 1170-1175

Dubus, S.éb.; Gravel, J.-F.ço.; Le Drogoff, B.; Nobert, P.; Veres, T.; Boudreau, D. 2006: PCR-free DNA detection using a magnetic bead-supported polymeric transducer and microelectromagnetic traps. Analytical Chemistry 78(13): 4457-4464

Zhou, L.; Yang, C.; Xiao, L. 2003: PCR-mediated recombination between Cryptosporidium spp. of lizards and snakes. Journal of Eukaryotic Microbiology 50 Suppl: 563-565

Ehler, E.; Marvan, R.; Mazura, I. 2006: PCR-multiplex system for analysis of Y-chromosomal microsatellite polymorphisms DYS449, DYS456, DYS458, and DYS464. Soudni Lekarstvi 51(2): 30-34

Wardak, S.; Szych, J.; Cieślik, A. 2005: PCR-restriction fragment length polymorphism assay (PCR-RFLP) as an useful tool for detection of mutation in gyrA gene at 86-THR position associated with fluoroquinolone resistance in Campylobacter jejuni. Medycyna Doswiadczalna i Mikrobiologia 57(3): 295-301

Roelofs, R.W.; Sprong, T.; de Kok, J.B.; Swinkels, D.W. 2003: PCR-restriction fragment length polymorphism method to detect the X/Y polymorphism in the promoter site of the mannose-binding lectin gene. Clinical Chemistry 49(9): 1557-1558

McBurney, W.; Mangold, M.; Munro, K.; Schultz, M.; Rath, H.C.; Tannock, G.W. 2006: PCR/DGGE and 16S rRNA gene library analysis of the colonic microbiota of HLA-B27/beta2-microglobulin transgenic rats. Letters in Applied Microbiology 42(2): 165-171

Cipollini, G.; Bevilacqua, G. 2005: PCR: potential and problems. Pathologica 97(4): 203-205

Gabbay, M.; Mathers, N.; Green, F.; Exley, D.; Atkins, T.; Gallagher, M.; Brayford, D. 2005: PCRTA serendipitous carrot masquerading as stick?. British Journal of General Practice: the Journal of the Royal College of General Practitioners 55(511): 156-157

Abifadel, M.; Rabès, J.-P.; Boileau, C.; Varret, M. 2006: PCSK9, from gene to protein: a new actor involved in cholesterol homeostasis. Medecine Sciences: M/S 22(11): 916-918

Lambert, G.; Costet, P.; Krempf, M.; Lalanne, F. 2004: PCSK9: a new gene involved in familial hypercholesteremia. Medecine Sciences: M/S 20(12): 1068-1070

Lambert, G.; Krempf, M.; Costet, P. 2006: PCSK9: a promising therapeutic target for dyslipidemias?. Trends in Endocrinology and Metabolism: Tem 17(3): 79-81

Hacking, J. 2003: PCT funding. Beggars belief. Health Service Journal 113(5850): 28-31

Hacking, J. 2005: PCT funding. the slice is right. Health Service Journal 115(5962): 18-19

Mooney, H. 2006: PCT fury over lost millions as PbR compensation withdrawn. Health Service Journal 116(5993): 5

Smith, J.; Goodwin, N.; Peck, E. 2003: PCT merger. Building bridges. Health Service Journal 113(5856): 24-26

Martin, D. 2005: PCT reconfiguration. first look at the primary care revolution. Health Service Journal 115(5979): 14-15

Harding, M.-L. 2005: PCT reform strategy slammed as 'intellectually incoherent'. Health Service Journal 115(5967): 5

Harding, M.-L. 2005: PCT reorganisation. the times they are a-changing the shape of primary care. Health Service Journal 115(5963): 14-15

Carlisle, D. 2007: PCT triage plans spark opposition. Health Service Journal 117(6042): 8

Harding, M.-L. 2005: PCT upheaval could kill clinical engagement, PEC chairs warn. Health Service Journal 115(5976): 5

Vaughan, V. 2007: PCTs fight UCLH over data validity. Health Service Journal 117(6040): 7

Martin, D. 2005: PCTs lament 'flawed' policy. Health Service Journal 115(5981): 8

Mooney, H. 2005: PCTs must work alongside councils. Health service journal 115(5946): 7

Dinsdale, P. 2006: PCTs told to implement radical changes to LAAs. Health Service Journal 116(6030): 8

Lloyd, I. 2005: PCTs will not be judged on commissioned services. Health Service Journal 115(5969): 8

Bratanich, A.C.; Blanchetot, A. 2002: PCV2 replicase transcripts in infected porcine kidney (PK15) cells. Virus Genes 25(3): 323-328

MacLin, O.H.; Zimmerman, L.A.; Malpass, R.S. 2005: PC_Eyewitness and the sequential superiority effect: computer-based lineup administration. Law and Human Behavior 29(3): 303-321

Erixon, M.; Lindén, T.ör.; Kjellstrand, P.; Carlsson, O.; Ernebrant, M.; Forsbäck, G.; Wieslander, A.; Jönsson, J.A. 2004: PD fluids contain high concentrations of cytotoxic GDPs directly after sterilization. Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis 24(4): 392-398

Phillips, M.L. 2006: PD gene and oxidative stress. Environmental Health Perspectives 114(2): A96

Ho-dac-Pannekeet, M.M. 2006: PD in the elderly--a challenge for the (pre)dialysis team. Nephrology Dialysis Transplantation: Official Publication of the European Dialysis and Transplant Association - European Renal Association 21(Suppl 2): Ii60-Ii62

Jörres, A.; Witowski, J. 2006: PD membrane: biological responses to different PD fluids. Contributions to Nephrology 150: 48-53

Kennedy, L. 2006: PD trivia: Making learning fun. Cannt Journal 16(3): 46-48

McSherry, B. 2003: PD v Harvey and Chen [2003] NSWSC 487. Journal of Law and Medicine 11(1): 18-19

Boileau, C.; Martel-Pelletier, J.; Brunet, J.; Schrier, D.; Flory, C.; Boily, M.; Pelletier, J.-P. 2006: PD-0200347, an alpha2delta ligand of the voltage gated calcium channel, inhibits in vivo activation of the Erk1/2 pathway in osteoarthritic chondrocytes: a PKCalpha dependent effect. Annals of the Rheumatic Diseases 65(5): 573-580

Sheppard, K.-A.; Fitz, L.J.; Lee, J.M.; Benander, C.; George, J.A.; Wooters, J.; Qiu, Y.; Jussif, J.M.; Carter, L.L.; Wood, C.R.; Chaudhary, D. 2004: PD-1 inhibits T-cell receptor induced phosphorylation of the ZAP70/CD3zeta signalosome and downstream signaling to PKCtheta. Febs Letters 574(1-3): 37-41

Zhang, J-Yuan.; Zhang, Z.; Wang, X.; Fu, J-Liang.; Yao, J.; Jiao, Y.; Chen, L.; Zhang, H.; Wei, J.; Jin, L.; Shi, M.; Gao, G.Fu.; Wu, H.; Wang, F-Sheng. 2007: PD-1 up-regulation is correlated with HIV-specific memory CD8+ T-cell exhaustion in typical progressors but not in long-term nonprogressors. Blood 109(11): 4671-4678

Steiert, M.; Schmitz, F.J. 2000: PD-140248 (Parke-Davis and Co). Idrugs: the Investigational Drugs Journal 3(2): 223-227

Inman, B.A.; Sebo, T.J.; Frigola, X.; Dong, H.; Bergstralh, E.J.; Frank, I.; Fradet, Y.; Lacombe, L.; Kwon, E.D. 2007: PD-L1 (B7-H1) expression by urothelial carcinoma of the bladder and BCG-induced granulomata: associations with localized stage progression. Cancer 109(8): 1499-1505

Waeckerle-Men, Y.; Starke, A.; Wüthrich, R.P. 2007: PD-L1 partially protects renal tubular epithelial cells from the attack of CD8+ cytotoxic T cells. Nephrology Dialysis Transplantation: Official Publication of the European Dialysis and Transplant Association - European Renal Association 22(6): 1527-1536

Saunders, P.A.; Hendrycks, V.R.; Lidinsky, W.A.; Woods, M.L. 2005: PD-L2:PD-1 involvement in T cell proliferation, cytokine production, and integrin-mediated adhesion. European Journal of Immunology 35(12): 3561-3569

Wan, Y.; Wang, T.; Zhao, Q. 2005: PD98059 inhibited the activation of pancreatic stellate cells mediated by platelet-derived growth factor BB in rats. Journal of Huazhong University of Science and Technology. Medical Sciences 25(3): 297-299; 306

Yuantai, W.; Tiancai, W.; Qiu, Z. 2005: PD98059 inhibits expression of pERK1 protein and collagen alpha1(I) mRNA in rat pancreatic stellate cells activated by platelet-derived growth factor. Indian Journal of Gastroenterology: Official Journal of the Indian Society of Gastroenterology 24(3): 100-103

Suthiphongchai, T.; Phimsen, S.; Sakulkhu, U.; Tohtong, R. 2006: PD98059-inhibited invasion of Dunning rat prostate cancer cells involves suppression of motility but not MMP-2 or uPA secretion. Oncology Reports 15(6): 1605-1610

Teske, E. 2005: PDA (Personal Digital Assistant) in the veterinary practice?. Tijdschrift Voor Diergeneeskunde 130(12): 380-381

Leong, W.Zhong.; Tan, S.Hao.; Ngoc, P.Cao.Thi.; Amanda, S.; Yam, A.Wei.Yee.; Liau, W-Siang.; Gong, Z.; Lawton, L.N.; Tenen, D.G.; Sanda, T. 2017: ARID5B as a critical downstream target of the TAL1 complex that activates the oncogenic transcriptional program and promotes T-cell leukemogenesis. Genes and Development 31(23-24): 2343-2360

Gordon, J.S.; McNew, R. 2005: PDA application for collecting patient encounter data for Advanced Practice nursing students in a clinical setting. AMIA . Annual Symposium Proceedings. AMIA Symposium 2005: 966

Park, K.-S.; Kim, N.-J.; Hong, J.-H.; Park, M.-S.; Cha, E.-J.; Lee, T.-S. 2005: PDA based Point-of-care Personal Diabetes Management System. Conference Proceedings: . Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual Conference 2005: 3749-3752

Sersar, S.Ibrahim.; Mooty, H.Abdel.; Hafez, M.Mohammed.; Ismail, M.Fouad.; Refaat, A.A.; Ibrahim, M.F. 2005: PDA ligation: trans or extrapleural approach. Annals of Thoracic Surgery 80(5): 1976; Author Reply 1976-7

Hitchcock, E.K. 2004: PDA members observe second annual Give Kids A Smile Day. Pennsylvania Dental Journal 71(3): 18-26

Schuerenberg, B.K. 2005: PDA software keeps plugging along. Health Data Management 13(9): 66; 68

Kirsch, L. 2004: PDA students. PDA Journal of Pharmaceutical Science and Technology 58(5): 241-242

Yoshihara, C.; Shimizu, S. 2005: Social networks in drinking behaviors among Japanese: support network, drinking network, and intervening network. Nihon Arukoru Yakubutsu Igakkai Zasshi 40(5): 441-454

Yang, H.-C.; Pan, C.-C.; Lin, C.-Y.; Fann, C.S.J. 2006: PDA: Pooled DNA analyzer. Bmc Bioinformatics 7: 233

Altmann, T.K.; Brady, D. 2005: PDAs bring information competence to the point-of-care. International Journal of Nursing Education Scholarship 2: Article 10

Cross, M. 2006: PDAs chase workflow improvements. Health Data Management 14(5): 61-62

Schuerenberg, B.K. 2004: PDAs for nothing and your apps for free. Health Data Management 12(4): 56-58; 60

Eastes, L. 2004: PDAs for the trauma nurse: help or hindrance?. Journal of Emergency Nursing 30(4): 380-383

Pergami, P. 2003: PDAs in clinical practice: having a database in your hand but keeping the decision in your brain. Neuroinformatics 1(2): 207-209

Armour, K. 2004: PDAs in nursing. Here's why & how to use this emerging clinical tool. Awhonn Lifelines 8(3): 241-247

Smith, C.M.; Pattillo, R.E. 2006: PDAs in the nursing curriculum: providing data for internal funding. Nurse Educator 31(3): 101-102

Schuerenberg, B.K. 2004: PDAs send EKG data stat. Health Data Management 12(6): 86; 88

Broscio, M.; Scherer, J. 2003: Six steps to creating a personal career-decision framework. Journal of Healthcare Management / American College of Healthcare Executives 48(6): 355-361

Chesanow, N. 2003: PDAs. how to choose software. Medical Economics 80(20): Tcp17

Jackson, G. 2005: PDE 5 inhibitors and HIV risk: current concepts and controversies. International Journal of Clinical Practice 59(11): 1247-1248

Torphy, T.J. 2000: PDE inhibitors--Second William Harvey Research Conference. Drugs with an expanding range of therapeutic uses. 1-3 December 1999, Nice, France. IDrugs: the investigational drugs journal 3(2): 170-173

Padma-Nathan, H. 2005: PDE-5 Inhibitor Therapy for Erectile Dysfunction Secondary to Nerve-Sparing Radical Retropubic Prostatectomy. Reviews in Urology 7(Suppl 2): S33-S38

Rosen, R.C.; McKenna, K.E. 2002: PDE-5 inhibition and sexual response: pharmacological mechanisms and clinical outcomes. Annual review of sex research 13: 36-88

Anonymous 2003: PDE-5 inhibitor with improved pharmacokinetics. Far-reaching return to normality. MMW Fortschritte der Medizin 145(11): 56-57

Deibert, P.; Bremer, H.; Roessle, M.; Kurz-Schmieg, A-K.; Kreisel, W. 2007: PDE-5 inhibitors lower portal and pulmonary pressure in portopulmonary hypertension. European Respiratory Journal 29(1): 220-221

Masson, P.; Lambert, S.M.; Brown, M.; Shabsigh, R. 2005: PDE-5 inhibitors: current status and future trends. Urologic Clinics of North America 32(4): 511

Kirby, M.G. 2006: PDE-5 inhibitors: spoilt for choice. International Journal of Clinical Practice 60(8): 893-894

Kim, S. 2006: PDE-based image restoration: a hybrid model and color image denoising. IEEE Transactions on Image Processing: a Publication of the IEEE Signal Processing Society 15(5): 1163-1170

Hassouna, M.S.; Farag, A.A. 2005: PDE-based three dimensional path planning for virtual endoscopy. Information Processing in Medical Imaging: Proceedings of the . Conference 19: 529-540

Movsesian, M.A. 2003: PDE3 inhibition in dilated cardiomyopathy: reasons to reconsider. Journal of Cardiac Failure 9(6): 475-480

Martin, T.J. 2001: PDE4 inhibitors - a review of the recent patent literature. Idrugs: the Investigational Drugs Journal 4(3): 312-338

Sanz, M.ía.J.ús.; Cortijo, J.; Morcillo, E.J. 2005: PDE4 inhibitors as new anti-inflammatory drugs: effects on cell trafficking and cell adhesion molecules expression. Pharmacology and Therapeutics 106(3): 269-297

Vignola, A.M. 2004: PDE4 inhibitors in COPD--a more selective approach to treatment. Respiratory Medicine 98(6): 495-503

Brunton, L.L. 2003: PDE4: arrested at the border. Science's Stke: Signal Transduction Knowledge Environment 204: Pe44

Worrall, B.B.; Mychaleckyj, J.C. 2006: PDE4D and stroke: a real advance or a case of the Emperor's new clothes?. Stroke 37(8): 1955-1957

Hackett, G. 2006: PDE5 inhibitors in diabetic peripheral neuropathy. International Journal of Clinical Practice 60(9): 1123-1126

Carson, C.C. 2006: PDE5 inhibitors: are there differences?. Canadian Journal of Urology 13(Suppl 1): 34-39

Jackson, G. 2003: PDE5 inhibitors: looking beyond ED. International Journal of Clinical Practice 57(3): 159-160

Wang, H.; Lee, Y.; Malbon, C.C. 2004: PDE6 is an effector for the Wnt/Ca2+/cGMP-signalling pathway in development. Biochemical Society Transactions 32(Part 5): 792-796

Johnson, K.W.; Lofland, D.; Moser, H.E. 2005: PDF inhibitors: an emerging class of antibacterial drugs. Current Drug Targets. Infectious Disorders 5(1): 39-52

Linay, D. 2006: PDFs judged a great success. Rcm Midwives: the Official Journal of the Royal College of Midwives 9(3): 96-97

McKinnon, R.D.; Waldron, S.; Kiel, M.E. 2005: PDGF alpha-receptor signal strength controls an RTK rheostat that integrates phosphoinositol 3'-kinase and phospholipase Cgamma pathways during oligodendrocyte maturation. Journal of Neuroscience: the Official Journal of the Society for Neuroscience 25(14): 3499-3508

Ottaviani, E.; Barbieri, D.; Franchini, A.; Kletsas, D. 2000: PDGF and TGF-beta partially prevent 2-deoxy-D-ribose-induced apoptosis in the fat body cell line IPLB-LdFB from the insect Lymantria dispar. Journal of Insect Physiology 46(1): 81-87

Jones, R.; Capen, D.; Jacobson, M. 2006: PDGF and microvessel wall remodeling in adult lung: imaging PDGF-Rbeta and PDGF-BB molecules in progenitor smooth muscle cells developing in pulmonary hypertension. Ultrastructural Pathology 30(4): 267-281

Jones, R.; Capen, D.; Jacobson, M.; Munn, L. 2006: PDGF and microvessel wall remodeling in adult rat lung: imaging PDGF-AA and PDGF-Ralpha molecules in progenitor smooth muscle cells developing in experimental pulmonary hypertension. Cell and Tissue Research 326(3): 759-769

Machens, H-Günther.; Niedworok, C.; Spanholtz, T.; Maichle, A. 2006: PDGF gene therapy enhances expression of VEGF and bFGF genes. Plastic and Reconstructive Surgery 118(3): 820; Author Reply 820-1

Wang, X.T.; Liu, P.Y.; Tang, J.B. 2006: PDGF gene therapy enhances expression of VEGF and bFGF genes and activates the NF-kappaB gene in signal pathways in ischemic flaps. Plastic and Reconstructive Surgery 117(1): 129-137; Discussion: 138-139

Chin, A.; Zheng, J.; Duignan, I.J.; Edelberg, J.M. 2006: PDGF-AB-based functional cardioprotection of the aging rat heart. Experimental Gerontology 41(1): 63-68

Bicanski, B.; Wenderdel, M.; Mertens, P.R.; Senderek, J.; Panzer, U.; Steinmetz, O.; Stahl, R.A.K.; Cerullo, G.; Diletta Torres, D.; Schena, F.P.; Zerres, K.; Floege, J. 2007: PDGF-B gene single-nucleotide polymorphisms are not predictive for disease onset or progression of IgA nephropathy. Clinical Nephrology 67(2): 65-72

Kagami, S.; Urushihara, M.; Kitamura, A.; Kondo, S.; Hisayama, T.; Kitamura, M.; Löster, K.; Reutter, W.; Kuroda, Y. 2004: PDGF-BB enhances alpha1beta1 integrin-mediated activation of the ERK/AP-1 pathway involved in collagen matrix remodeling by rat mesangial cells. Journal of Cellular Physiology 198(3): 470-478

Westhoff, J.H.; Sawitza, I.; Keski-Oja, J.; Gressner, A.M.; Breitkopf, K. 2003: PDGF-BB induces expression of LTBP-1 but not TGF-beta1 in a rat cirrhotic fat storing cell line. Growth Factors 21(3-4): 121-130

Floege, J.ür.; Eitner, F.; Van Roeyen, C.; Ostendorf, T. 2003: PDGF-D and renal disease: yet another one of those growth factors?. Journal of the American Society of Nephrology: Jasn 14(10): 2690-2691

Liegl, B.; Reich, O.; Nogales, F.F.; Regauer, S. 2006: PDGF-alpha and PDGF-beta are expressed in endometrial stromal sarcoma: a potential therapeutic target for tyrosine kinase inhibitors?. Histopathology 49(5): 545-546

Adams, S.F.; Hickson, J.A.; Hutto, J.Y.; Montag, A.G.; Lengyel, E.; Yamada, S.D. 2007: PDGFR-alpha as a potential therapeutic target in uterine sarcomas. Gynecologic Oncology 104(3): 524-528

Xu, X.; Bringas, P.; Soriano, P.; Chai, Y. 2005: PDGFR-alpha signaling is critical for tooth cusp and palate morphogenesis. Developmental Dynamics: An Official Publication of the American Association of Anatomists 232(1): 75-84

Shinohara, E.T.; Gonzalez, A.; Massion, P.P.; Olson, S.J.; Albert, J.M.; Shyr, Y.; Carbone, D.P.; Johnson, D.H.; Hallahan, D.E.; Lu, B. 2007: PDGFR-beta expression in small cell lung cancer patients. International Journal of Radiation Oncology Biology Physics 67(2): 431-437

Chompret, A.ès.; Kannengiesser, C.; Barrois, M.; Terrier, P.; Dahan, P.; Tursz, T.; Lenoir, G.M.; Bressac-De Paillerets, B. 2004: PDGFRA germline mutation in a family with multiple cases of gastrointestinal stromal tumor. Gastroenterology 126(1): 318-321

Corless, C.L.; Schroeder, A.; Griffith, D.; Town, A.; McGreevey, L.; Harrell, P.; Shiraga, S.; Bainbridge, T.; Morich, J.; Heinrich, M.C. 2005: PDGFRA mutations in gastrointestinal stromal tumors: frequency, spectrum and in vitro sensitivity to imatinib. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 23(23): 5357-5364

Lagonigro, M.S.; Tamborini, E.; Negri, T.; Staurengo, S.; Dagrada, G.P.; Miselli, F.; Gabanti, E.; Greco, A.; Casali, P.G.; Carbone, A.; Pierotti, M.A.; Pilotti, S. 2006: PDGFRalpha, PDGFRbeta and KIT expression/activation in conventional chondrosarcoma. Journal of Pathology 208(5): 615-623

Jenkinson, W.E.; Rossi, S.W.; Parnell, S.M.; Jenkinson, E.J.; Anderson, G. 2007: PDGFRalpha-expressing mesenchyme regulates thymus growth and the availability of intrathymic niches. Blood 109(3): 954-960

Schneider, L.; Clement, C.A.; Teilmann, S.C.; Pazour, G.J.; Hoffmann, E.K.; Satir, P.; Christensen, S.ør.T. 2005: PDGFRalphaalpha signaling is regulated through the primary cilium in fibroblasts. Current Biology: Cb 15(20): 1861-1866

Pilegaard, H.; Birk, J.B.; Sacchetti, M.; Mourtzakis, M.; Hardie, D.G.; Stewart, G.; Neufer, P.D.; Saltin, B.; van Hall, G.; Wojtaszewski, J.F.P. 2006: PDH-E1alpha dephosphorylation and activation in human skeletal muscle during exercise: effect of intralipid infusion. Diabetes 55(11): 3020-3027

Toker, A. 2003: PDK-1 and protein kinase C phosphorylation. Methods in Molecular Biology 233: 171-189

Lee, K.-Y.; D'Acquisto, F.; Hayden, M.S.; Shim, J.-H.; Ghosh, S. 2005: PDK1 nucleates T cell receptor-induced signaling complex for NF-kappaB activation. Science 308(5718): 114-118

Hall, M.; Masella, R.; Meister, M. 2001: PDL neuron-associated neurotransmitters in orthodontic tooth movement: identification and proposed mechanism of action. Today's Fda: Official Monthly Journal of the Florida Dental Association 13(2): 24-25

Vanaja, D.K.; Ballman, K.V.; Morlan, B.W.; Cheville, J.C.; Neumann, R.M.; Lieber, M.M.; Tindall, D.J.; Young, C.Y.F. 2006: PDLIM4 repression by hypermethylation as a potential biomarker for prostate cancer. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 12(4): 1128-1136

Verrier, S.; Blaker, J.J.; Maquet, V.; Hench, L.L.; Boccaccini, A.R. 2004: PDLLA/Bioglass composites for soft-tissue and hard-tissue engineering: an in vitro cell biology assessment. Biomaterials 25(15): 3013-3021

Camou, S.; Fujita, H.; Fujii, T. 2003: PDMS 2D optical lens integrated with microfluidic channels: principle and characterization. Lab on a Chip 3(1): 40-45

Haubert, K.; Drier, T.; Beebe, D. 2006: PDMS bonding by means of a portable, low-cost corona system. Lab on a Chip 6(12): 1548-1549

Spiller, D.; Losi, P.; Briganti, E.; Sbrana, S.; Kull, S.; Martinelli, I.; Soldani, G. 2007: PDMS content affects in vitro hemocompatibility of synthetic vascular grafts. Journal of Materials Science. Materials in Medicine 18(6): 1097-1104

Li, C-Wing.; Cheung, C.Nam.; Yang, J.; Tzang, C.Hung.; Yang, M. 2003: PDMS-based microfluidic device with multi-height structures fabricated by single-step photolithography using printed circuit board as masters. Analyst 128(9): 1137-1142

Dodge, A.; Brunet, E.; Chen, S.; Goulpeau, J.; Labas, V.ér.; Vinh, J.; Tabeling, P. 2006: PDMS-based microfluidics for proteomic analysis. Analyst 131(10): 1122-1128

Chuenkova, M.V.; Pereira, M.A. 2003: PDNF, a human parasite-derived mimic of neurotrophic factors, prevents caspase activation, free radical formation, and death of dopaminergic cells exposed to the Parkinsonism-inducing neurotoxin MPP+. Brain Research. Molecular Brain Research 119(1): 50-61

Benito, J.; Zheng, H.; Hardin, P.E. 2007: PDP1epsilon functions downstream of the circadian oscillator to mediate behavioral rhythms. Journal of Neuroscience: the Official Journal of the Society for Neuroscience 27(10): 2539-2547

Singerman, L.J.; Weaver, D.T. 1981: PDR in juvenile onset diabetics: high-risk proliferative diabetic retinopathy in juvenile onset diabetics. Retina 1(1): 18-26

Jinman, P.; Scott-Park, F. 2003: PDSA National PetCheck Week. Veterinary Record 153(5): 155

Szlachta, Z.; Frankiewicz, A.; Stołtny, T.; Koczy, B.; Spindel, J.; Walentek, T.; Sieroń-Stołtny, K.; Krawczyk-Krupka, A.; Sieroń, A. 2006: PDT photodynamic therapy in orthopedic inflammatory conditions?. Chirurgia Narzadow Ruchu i Ortopedia Polska 71(2): 133-136

Korbelik, M. 2006: PDT-associated host response and its role in the therapy outcome. Lasers in Surgery and Medicine 38(5): 500-508

Brown, M. 2003: PDT: light at the end of the tunnel?. Drug Discovery Today 8(17): 767-768

Mori, Y.; Tsukahara, H.; Jiang, M.-Z.; Mayumi, M. 2005: PDTC and NO suppress CC chemokine production in TNF-alpha-stimulated human pulmonary microvascular endothelial cells. Respiratory Medicine 99(8): 1068-1069

Moon, S.-K.; Jung, S.-Y.; Choi, Y.-H.; Lee, Y.-C.; Patterson, C.; Kim, C.-H. 2004: PDTC, metal chelating compound, induces G1 phase cell cycle arrest in vascular smooth muscle cells through inducing p21Cip1 expression: involvement of p38 mitogen activated protein kinase. Journal of Cellular Physiology 198(2): 310-323

Liu, T.; Wang, C.; Wan, C.; Xiong, J.; Xu, Y.; Zhou, F. 2004: PDX-1 expression in pancreatic ductal cells after partial pancreatectomy in adult rats. Journal of Huazhong University of Science and Technology. Medical Sciences 24(5): 464-466

Noguchi, H.; Matsumoto, S.; Okitsu, T.; Iwanaga, Y.; Yonekawa, Y.; Nagata, H.; Matsushita, M.; Wei, F.-Y.; Matsui, H.; Minami, K.; Seino, S.; Masui, Y.; Futaki, S.; Tanaka, K. 2005: PDX-1 protein is internalized by lipid raft-dependent macropinocytosis. Cell Transplantation 14(9): 637-645

Xie, L.; Yamamoto, B.; Haoudi, A.; Semmes, O.John.; Green, P.L. 2006: PDZ binding motif of HTLV-1 Tax promotes virus-mediated T-cell proliferation in vitro and persistence in vivo. Blood 107(5): 1980-1988

Bilder, D. 2003: PDZ domain polarity complexes. Current Biology: Cb 13(17): R661-R662

Dev, K.K. 2007: PDZ domain protein-protein interactions: a case study with PICK1. Current Topics in Medicinal Chemistry 7(1): 3-20

Nourry, C.; Grant, S.G.N.; Borg, J.-P. 2003: PDZ domain proteins: plug and play!. Science's Stke: Signal Transduction Knowledge Environment 179: Re7

Tsubata, C.; Higuchi, M.; Takahashi, M.; Oie, M.; Tanaka, Y.; Gejyo, F.; Fujii, M. 2005: PDZ domain-binding motif of human T-cell leukemia virus type 1 Tax oncoprotein is essential for the interleukin 2 independent growth induction of a T-cell line. Retrovirology 2: 46

Zimmermann, P. 2006: PDZ domain-phosphoinositide interactions in cell-signaling. Verhandelingen - Koninklijke Academie Voor Geneeskunde van Belgie 68(4): 271-286

Jeleń, F.; Oleksy, A.; Smietana, K.; Otlewski, J. 2003: PDZ domains - common players in the cell signaling. Acta Biochimica Polonica 50(4): 985-1017

Hernando, N.; Wagner, C.A.; Gisler, S.M.; Biber, J.ür.; Murer, H. 2004: PDZ proteins and proximal ion transport. Current Opinion in Nephrology and Hypertension 13(5): 569-574

Sierralta, J.; Mendoza, C. 2004: PDZ-containing proteins: alternative splicing as a source of functional diversity. Brain Research. Brain Research Reviews 47(1-3): 105-115

Day, P.; Kobilka, B. 2006: PDZ-domain arrays for identifying components of GPCR signaling complexes. Trends in Pharmacological Sciences 27(10): 509-511

Tian, F.; Zhang, X.; Tong, Y.; Yi, Y.; Zhang, S.; Li, L.; Sun, P.; Lin, L.; Ding, J. 2005: PE, a new sulfated saponin from sea cucumber, exhibits anti-angiogenic and anti-tumor activities in vitro and in vivo. Cancer Biology and Therapy 4(8): 874-882

Anonymous 2006: PE-RVU changes could cut major procedures by 10 percent. Medicine and Health 60(35): 7-8

Sharif, A.; Canton, B.; Junier, M.-P.; Chneiweiss, H.é 2003: PEA-15 modulates TNFalpha intracellular signaling in astrocytes. Annals of the new York Academy of Sciences 1010: 43-50

De Launoit, Y.; Baert, J.-L.; Chotteau-Lelievre, A.; Monte, D.; Coutte, L.; Mauen, S.éb.; Firlej, V.; Degerny, C.; Verreman, K. 2006: PEA3 family of transcription factors and the regulation of oncogenesis. Bulletin du Cancer 93(10): 985-989

Davidson, B.; Goldberg, I.; Gotlieb, W.H.; Kopolovic, J.; Ben-Baruch, G.; Reich, R. 2003: PEA3 is the second Ets family transcription factor involved in tumor progression in ovarian carcinoma. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 9(4): 1412-1419

Kriete, A.; Boyce, K. 2005: Automated tissue analysis--a bioinformatics perspective. Methods of Information in Medicine 44(1): 32-37

Liebson, P.R. 2005: PEACE and CAMELOT. Preventive Cardiology 8(2): 127-129

Komeiji, Y.; Inadomi, Y.; Nakano, T. 2004: PEACH 4 with ABINIT-MP: a general platform for classical and quantum simulations of biological molecules. Computational Biology and Chemistry 28(2): 155-161

Raj, A. 2004: PEARLS home based treatment significantly improves depression, dysthymia, and health related quality of life in older people. Evidence-Based Mental Health 7(4): 110

Han, L.Y.; Lin, H.H.; Li, Z.R.; Zheng, C.J.; Cao, Z.W.; Xie, B.; Chen, Y.Z. 2006: PEARLS: program for energetic analysis of receptor-ligand system. Journal of Chemical Information and Modeling 46(1): 445-450

Gaugler, M.-H.; Vereycken-Holler, V.; Squiban, C.; Aigueperse, J. 2004: PECAM-1 (CD31) is required for interactions of platelets with endothelial cells after irradiation. Journal of Thrombosis and Haemostasis: Jth 2(11): 2020-2026

Biswas, P.; Canosa, S.; Schoenfeld, D.; Schoenfeld, J.; Li, P.; Cheas, L.C.; Zhang, J.; Cordova, A.; Sumpio, B.; Madri, J.A. 2006: PECAM-1 affects GSK-3beta-mediated beta-catenin phosphorylation and degradation. American Journal of Pathology 169(1): 314-324

Wang, S.; Dangerfield, J.P.; Young, R.E.; Nourshargh, S. 2005: PECAM-1, alpha6 integrins and neutrophil elastase cooperate in mediating neutrophil transmigration. Journal of Cell Science 118(Part 9): 2067-2076

Zocchi, M.R.; Poggi, A. 2004: PECAM-1, apoptosis and CD34+ precursors. Leukemia and Lymphoma 45(11): 2205-2213

Salazar, J. 2004: PECSH negotiating team hones its skills. Michigan Nurse 16: 18

Benítez Ahrendts, M.R.; Carrillo, L. 2005: Penicillium-inhibiting yeasts. Revista Argentina de Microbiologia 36(4): 182-186

Lenzer, T.; Luther, K.; Nilsson, D.; Nordholm, S. 2005: PECT model analysis and predictions of experimental collisional energy transfer probabilities P(E',E) and moments for azulene and biphenylene. Journal of Physical Chemistry. B 109(17): 8325-8331

Grunewald, M.; Talanow, R.; Wagner, M.; Spörl, M.; Greess, H.; Bautz, W.A.; Uhl, M. 2004: PEDBONE: the online reference database in paediatric plain film radiography. Pediatric Radiology 34(12): 1029

Eichler, W.; Yafai, Y.; Keller, T.; Wiedemann, P.; Reichenbach, A. 2004: PEDF derived from glial Müller cells: a possible regulator of retinal angiogenesis. Experimental Cell Research 299(1): 68-78

Ek, E.T.H.; Dass, C.R.; Choong, P.F.M. 2006: PEDF: a potential molecular therapeutic target with multiple anti-cancer activities. Trends in Molecular Medicine 12(10): 497-502

Marciniak, K.; Butwicka, A.; Nowak, J.Z. 2006: PEDF: an endogenous factor displaying potent neuroprotective, neurotrophic, and antiangiogenic activity. Postepy Higieny i Medycyny Doswiadczalnej 60: 387-396

Yeh, S.H. 2005: PEDIARIX: clinical trials. Expert Review of Vaccines 4(2): 139-145

Meltzer, L.E.; Bockman, A.A.; Kanenson, W.; Cohen, A. 1958: The incidence of peptic ulcer among patients on long term prednisone therapy. Gastroenterology 35(4): 351-356

Gibson, J.M. 1953: Alabama's hospitals, past, present and future. Journal of the Medical Association of the State of Alabama 23(1): 26-28

Gill, D.G. 1951: Carbon monoxide in heating systems. Journal of the Medical Association of the State of Alabama 20(10): 380-383

Harris, S. 1951: Health: Alabama's most profitable investment. Journal of the Medical Association of the State of Alabama 20(11): 415-418

Bond, E.D. 1954: Results of treatment in psychoses with a control series. II. Involutional psychotic reaction. American Journal of Psychiatry 110(12): 881-883

Anonymous 1955: PEDIATRIC proctology; megacolon. American Journal of Proctology 6(2): 154-157

Beattie, J.; Bell, D.J. 1953: Experiments concerning the renal clearances of some fructosans in the dog. Quarterly Journal of Experimental Physiology and Cognate Medical Sciences 38(1): 1-10

Kershaw, J.D. 1950: School health in England and Wales. Pediatrics 5(4): 757-758

Anonymous 1952: PEDIATRICS put in Part III National Board Examination. Journal of Pediatrics 40(4): 535-536

Bramson, R.T.; Taylor, G.A.; Blinder, R. 2005: PEDRAP: a new training alternative for pediatric radiologists. Pediatric Radiology 35(4): 454-455

Leitao, J.A.; Pedro V 1962: PEDRO V and homeopathy. Jornal Da Sociedade das Ciencias Medicas de Lisboa 126: 235-254

Luecke, T.; Roth, H.; Herrmann, P.; Joachim, A.; Weisser, G.; Pelosi, P.; Quintel, M. 2003: PEEP decreases atelectasis and extravascular lung water but not lung tissue volume in surfactant-washout lung injury. Intensive Care Medicine 29(11): 2026-2033

Schreiber, T.; Hueter, L.; Gaser, E.; Schmidt, B.; Schwarzkopf, K.; Rek, H.; Karzai, W. 2006: PEEP has beneficial effects on inflammation in the injured and no deleterious effects on the noninjured lung after unilateral lung acid instillation. Intensive Care Medicine 32(5): 740-749

Levy, M.M. 2004: PEEP in ARDS--how much is enough?. New England Journal of Medicine 351(4): 389-391

Slutsky, A.S.; Hudson, L.D. 2006: PEEP or no PEEP--lung recruitment may be the solution. New England Journal of Medicine 354(17): 1839-1841

Monkman, S.; Kirpalani, H. 2003: PEEP--a "cheap" and effective lung protection. Paediatric Respiratory Reviews 4(1): 15-20

Tymińska, K.; Grzelewska-Rzymowska, I. 2003: PEF measurements in diagnosis and monitoring of bronchial asthma. Pneumonologia i Alergologia Polska 71(5-6): 273-280

Judd, W.J.; Dake, L. 2001: PEG adsorption of autoantibodies causes loss of concomitant alloantibody. Immunohematology 17(3): 82-85

Maruyama, M. 2004: PEG and home nutrition care. Gan to Kagaku Ryoho. Cancer and ChemoTherapy 31(Suppl 2): 157-158

Lemke, R. 2003: PEG installation in patients unable to give informed consent. Deutsche Medizinische Wochenschrift 128(4): 160

Wejda, B.U.J.; Deppe, H.; Huchzermeyer, H.; Dormann, A.J. 2005: PEG placement in patients with ascites: a new approach. Gastrointestinal Endoscopy 61(1): 178-180

Sanders, D.S.; Hurlstone, D.P.; McAlindon, M.E. 2004: PEG placement in patients with dementia: a contentious ethical and clinical dilemma?. Gastrointestinal Endoscopy 60(3): 492; Author Reply 492-3

Akner, G. 2005: PEG treatment: an increasing dilemma. Age and Ageing 34(4): 320-321

Maetani, I.; Tada, T.; Ukita, T.; Inoue, H.; Sakai, Y.; Yoshikawa, M. 2003: PEG with introducer or pull method: a prospective randomized comparison. Gastrointestinal Endoscopy 57(7): 837-841

Parrish, B.; Breitenkamp, R.B.; Emrick, T. 2005: PEG- and peptide-grafted aliphatic polyesters by click chemistry. Journal of the American Chemical Society 127(20): 7404-7410

Ben-Shabat, S.; Kumar, N.; Domb, A.J. 2006: PEG-PLA block copolymer as potential drug carrier: preparation and characterization. Macromolecular Bioscience 6(12): 1019-1025

Hiemstra, C.; Zhong, Z.; Dijkstra, P.J.; Feijen, J. 2005: PEG-PLA hydrogels by stereocomplexation for tissue engineering of cartilage. Journal of Controlled Release: Official Journal of the Controlled Release Society 101(1-3): 332-334

Vila, A.; Sánchez, A.; Evora, C.; Soriano, I.; Vila Jato, J.L.; Alonso, M.J. 2004: PEG-PLA nanoparticles as carriers for nasal vaccine delivery. Journal of Aerosol Medicine: the Official Journal of the International Society for Aerosols in Medicine 17(2): 174-185

Davis, F.F. 2003: PEG-adenosine deaminase and PEG-asparaginase. Advances in Experimental Medicine and Biology 519: 51-58

Karinaga, R.; Koumoto, K.; Mizu, M.; Anada, T.; Shinkai, S.; Sakurai, K. 2005: PEG-appended beta-(1-->3)-D-glucan schizophyllan to deliver antisense-oligonucleotides with avoiding lysosomal degradation. Biomaterials 26(23): 4866-4873

Weber, L.M.; He, J.; Bradley, B.; Haskins, K.; Anseth, K.S. 2006: PEG-based hydrogels as an in vitro encapsulation platform for testing controlled beta-cell microenvironments. Acta Biomaterialia 2(1): 1-8

Fu, R.; Xu, T.; Wang, G.; Yang, W.; Pan, Z. 2003: PEG-catalytic water splitting in the interface of a bipolar membrane. Journal of Colloid and Interface Science 263(2): 386-390

Fisher, T.C. 2000: PEG-coated red blood cells-simplifying blood transfusion in the new millennium?. Immunohematology 16(1): 37-48

Bhattarai, N.; Matsen, F.A.; Zhang, M. 2005: PEG-grafted chitosan as an injectable thermoreversible hydrogel. Macromolecular Bioscience 5(2): 107-111

Heise, M.; Schmidmaier, G.; Husmann, I.; Heidenhain, C.; Schmidt, J.; Neuhaus, P.; Settmacher, U. 2006: PEG-hirudin/iloprost coating of small diameter ePTFE grafts effectively prevents pseudointima and intimal hyperplasia development. European Journal of Vascular and Endovascular Surgery: the Official Journal of the European Society for Vascular Surgery 32(4): 418-424

Hoffman, R.M. 2003: PEG-methioninase. Advances in Experimental Medicine and Biology 519: 69-79

Vakil, R.; Kwon, G.S. 2005: PEG-phospholipid micelles for the delivery of amphotericin B. Journal of Controlled Release: Official Journal of the Controlled Release Society 101(1-3): 386-389

Darlington, C. 2003: PEG-sTNF-RI. Amgen. Current Opinion in Investigational Drugs 4(5): 583-587

Cernovská, K.; Kemter, M.; Gallmeier, H.-C.; Rzepecki, P.; Schrader, T.; König, B. 2004: PEG-supported synthesis of pyrazole oligoamides with peptide beta-sheet affinity. Organic and Biomolecular Chemistry 2(11): 1603-1611

Hu, C.; Xiong, J.; Zhang, L.; Huang, B.; Zhang, Q.; Li, Q.; Yang, M.; Wu, Y.; Wu, Q.; Shen, Q.; Gao, Q.; Zhang, K.; Sun, Z.; Liu, J.; Jin, Y.; Tan, J. 2004: PEG10 activation by co-stimulation of CXCR5 and CCR7 essentially contributes to resistance to apoptosis in CD19+CD34+ B cells from patients with B cell lineage acute and chronic lymphocytic leukemia. Cellular and Molecular Immunology 1(4): 280-294

Derkaoui, N.; Said, S.èr.; Grohens, Y.; Olier, R.é; Privat, M. 2007: PEG400 novel phase description in water. Journal of Colloid and Interface Science 305(2): 330-338

Breier-Mackie, S.J. 2005: PEGs and ethics revisited: a timely reflection in the wake of the Terri Schiavo case. Gastroenterology Nursing: the Official Journal of the Society of Gastroenterology Nurses and Associates 28(4): 292-297

Eto, Y.; Gao, J.-Q.; Sekiguchi, F.; Kurachi, S.; Katayama, K.; Maeda, M.; Kawasaki, K.; Mizuguchi, H.; Hayakawa, T.; Tsutsumi, Y.; Mayumi, T.; Nakagawa, S. 2005: PEGylated adenovirus vectors containing RGD peptides on the tip of PEG show high transduction efficiency and antibody evasion ability. Journal of Gene Medicine 7(5): 604-612

Chekhonin, V.P.; Zhirkov, Y.A.; Gurina, O.I.; Ryabukhin, I.A.; Lebedev, S.V.; Kashparov, I.A.; Dmitriyeva, T.B. 2005: PEGylated immunoliposomes directed against brain astrocytes. Drug Delivery 12(1): 1-6

Hinds, K.D.; Campbell, K.M.; Holland, K.M.; Lewis, D.H.; Piché, C.A.; Schmidt, P.G. 2005: PEGylated insulin in PLGA microparticles. In vivo and in vitro analysis. Journal of Controlled Release: Official Journal of the Controlled Release Society 104(3): 447-460

Ramon, J.; Saez, V.; Baez, R.; Aldana, R.; Hardy, E. 2005: PEGylated interferon-alpha2b: a branched 40K polyethylene glycol derivative. Pharmaceutical Research 22(8): 1374-1386

Fukushima, S.; Miyata, K.; Nishiyama, N.; Kanayama, N.; Yamasaki, Y.; Kataoka, K. 2005: PEGylated polyplex micelles from triblock catiomers with spatially ordered layering of condensed pDNA and buffering units for enhanced intracellular gene delivery. Journal of the American Chemical Society 127(9): 2810-2811

Hosseinkhani, H.; Tabata, Y. 2004: PEGylation enhances tumor targeting of plasmid DNA by an artificial cationized protein with repeated RGD sequences, Pronectin. Journal of Controlled Release: Official Journal of the Controlled Release Society 97(1): 157-171

Croyle, M.A.; Callahan, S.M.; Auricchio, A.; Schumer, G.; Linse, K.D.; Wilson, J.M.; Brunner, L.J.; Kobinger, G.P. 2004: PEGylation of a vesicular stomatitis virus G pseudotyped lentivirus vector prevents inactivation in serum. Journal of Virology 78(2): 912-921

Esposito, P.; Barbero, L.; Caccia, P.; Caliceti, P.; D'Antonio, M.; Piquet, G.; Veronese, F.M. 2003: PEGylation of growth hormone-releasing hormone (GRF) analogues. Advanced Drug Delivery Reviews 55(10): 1279-1291

Ichikawa, K.; Hikita, T.; Maeda, N.; Takeuchi, Y.; Namba, Y.; Oku, N. 2004: PEGylation of liposome decreases the susceptibility of liposomal drug in cancer photodynamic therapy. Biological and Pharmaceutical Bulletin 27(3): 443-444

Feng, M.; Li, P. 2005: PEI-PMMA cationic nanoparticles as carriers for gene transfer. Yao Xue Xue Bao 40(10): 893-897

McNatt, S.S.; Howard-McNatt, M. 2002: Contemporary surgical management of obesity. West Virginia Medical Journal 98(6): 273-277

Magee, J.C.; Feng, S. 2005: PELD: working well, but only half of the time?. American Journal of Transplantation: Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons 5(8): 1785-1786

Biglino, D.; Schmidt, P.P.; Reijerse, E.J.; Lubitz, W. 2006: PELDOR study on the tyrosyl radicals in the R2 protein of mouse ribonucleotide reductase. Physical Chemistry Chemical Physics: Pccp 8(1): 58-62

Anonymous 1955: PELLAGRA and secondary Vincent's infection. Postgraduate Medicine 17(3): 8-9

Anonymous 1957: PELLAGRA and the cooking of corn. Nutrition Reviews 15(2): 53-55

Anonymous 1955: PELLAGRA secondary to antiobesity diet. Postgraduate Medicine 17(3): 37

Anonymous 1955: PELLAGRA secondary to tuberculosis. Postgraduate Medicine 17(3): 38-39

Anonymous 1955: PELLAGROUS dermatitis; secondary to hypertensive heart disease. Postgraduate Medicine 17(3): 35-37

Anonymous 1955: PELLAGROUS psychosis. Postgraduate Medicine 17(3): 70

Mathon, K.; Pelnar 1962: PELNAR'S contribution to Czechoslovakian neurology. Casopis Lekaru Ceskych 101: 1401-1404

Anonymous 1952: PELVIMETRY: analysis of 1000 cases. Medical Journal of Australia 2(15): 513-515

Girard, Céline.; Bigorre, Mèle.; Guillot, B.; Bessis, D. 2006: PELVIS Syndrome. Archives of Dermatology 142(7): 884-888

Herman, M.; Godambe, S.; Pershad, J. 2004: PEM physicians can safely and effectively administer propofol. Pediatric emergency care 20(9): 648-9; author reply 649

Saltzman, C.; Lightfoot, A.; Amendola, A. 2004: PEMF as treatment for delayed healing of foot and ankle arthrodesis. Foot and Ankle International 25(11): 771-773

Anonymous 1953: PEMPHIGUS vulgaris dermatitis herpetiformis; case for diagnosis: bullous eruption. A.M.A. Archives of Dermatology and Syphilology 68(1): 102-104

Brenner, S.; Mashiah, J.; Tamir, E.; Goldberg, I.; Wohl, Y. 2003: PEMPHIGUS: an acronym for a disease with multiple etiologies. Skinmed 2(3): 163-167

Jackson, C.L.; Moreira, F.E.Godoy. 1955: PEN PORTRAITS of distinguished fellows. Journal of the International College of Surgeons 23(2 Pt 2): 33-34

Brunschwig, A.; Lederer, F.L. 1954: PEN PORTRAITS of distinguished fellows of the International College of Surgeons. Journal of the International College of Surgeons 22(6 Pt 2): 217-219

Anonymous 1951: PENDING federal bills. Ohio State Medical Journal 47(12): 1150-1151

Weinzimer, S.A. 2004: PENDRA: the once and future noninvasive continuous glucose monitoring device?. Diabetes Technology and Therapeutics 6(4): 442-444

Anonymous 1952: PENDULUM swinging. British Medical Journal 1(4759): 665

Bill, M.; Gill, P.; Curran, J.; Clayton, T.; Pinchin, R.; Healy, M.; Buckleton, J. 2005: PENDULUM--a guideline-based approach to the interpretation of STR mixtures. Forensic Science International 148(2-3): 181-189

Anonymous 1959: PENETRATING a tumour virus. Lancet 2(7092): 76-77

Anonymous 1959: PENETRATING the homograft barrier. Lancet 1(7062): 31-32

Anonymous 1951: PENETRATING wounds of the chest. Medical World 74(3): 82-86

Epifanio, C.; Burgos, R. 1953: Clinical and anatomicoradiologic aspect of pulmonary tuberculosis in the adult. Hoja Tisiologica 13(3): 239-254

Anonymous 1959: PENICILLIN V for pneumonia. Lancet 1(7076): 773

Damle, S.P.; Krishnan, P.S. 1956: Phosphate compounds occurring in spore washings of Aspergillus niger. Applied Microbiology 4(4): 179-182

Anonymous 1951: PENICILLIN and the prevention of acute rheumatic fever. Medical Journal of Australia 2(17): 569-570

Anonymous 1951: PENICILLIN dissolved in flaxedil. British Medical Journal 2(4739): 1095

Anonymous 1959: PENICILLIN in germ-free chicks. Nutrition Reviews 17(8): 236-238

Anonymous 1952: PENICILLIN in the lungs. British Medical Journal 1(4770): 1238-1239

Anonymous 1953: PENICILLIN in tissue fluids. British Medical Journal 1(4822): 1266-1267

Anonymous 1958: PENICILLIN-resistant gonococci. New England Journal of Medicine 259(6): 302-303

Anonymous 1950: PENICILLIN-resistant subacute bacterial endocarditis. American Journal of Medicine 8(6): 794-804

Anonymous 1958: PENNSYLVANIA Hospital. Medical Times 86(10): 1300-1307

Anonymous 1951: PENNSYLVANIA Hospital celebrates bicentenary. Hospital Progress 32(5): 138-139

Anonymous 1951: PENNSYLVANIA Hospital, a towering symbol of man's humanity to man. Hospital Management 71(1): 51

Bugbee, G. 1951: Should emergency maternity and infant care (EMIC) be reactivated?. Hospitals 25(5): 59-61

Anonymous 1951: PENNSYLVANIA Hospital... nursing department. Hospital Management 71(1): 68; passim

Anonymous 1951: PENNSYLVANIA Hospital: dietary department. Hospital Management 71(1): 96; passim

Rochette, M. 1953: Examination of the patient with calculi of the submaxillary gland or inflammation of the submaxillary duct. L' Information Dentaire 35(38): 1188

Anonymous 1959: PENNSYLVANIA hospital opens modern psychiatric unit. Mental Hospitals 10: 36-39

Anonymous 1956: PENNSYLVANIA is entering a new public health era. Pennsylvania Medical Journal 59(7): Suppl. 1-8

McGINNIS, J.N. 1951: The case for portion ready meats in hospital food purchasing. Hospital Management 71(1): 98

Day, D.I. 1953: Labor-saving laundry trends. Hospital Progress 34(1): 106; Passim

Aguayo, A.J.; Freund, Tás.; Huck, S. 2005: PENS, the new joint Programme for European Neuroscience Schools: FENS and IBRO turn past into future. Trends in Neurosciences 28(10): 507-508

Anonymous 1952: PENSIONER medical service. Medical Journal of Australia 2(13): 452-453

Sharland, M.; Blanche, S.; Castelli, G.; Ramos, J.; Gibb, D.M. 2004: PENTA guidelines for the use of antiretroviral therapy, 2004. HIV Medicine 5 Suppl. 2: 61-86

Lu, C.; Pelton, R. 2002: PEO flocculation with phenolic microparticles. Journal of Colloid and Interface Science 254(1): 101-107

Keleş, S.ün.üz.; van der Laan, M.J.; Dudoit, S.; Cawley, S.E. 2006: Multiple testing methods for ChIP-Chip high density oligonucleotide array data. Journal of Computational Biology: a Journal of Computational Molecular Cell Biology 13(3): 579-613

Choi, H.S.; An, J.J.; Kim, S.Y.; Lee, S.H.; Kim, D.W.; Yoo, K.-Y.; Won, M.H.; Kang, T.-C.; Kwon, H.J.; Kang, J.H.; Cho, S.-W.; Kwon, O.-S.; Park, J.; Eum, W.S.; Choi, S.Y. 2006: PEP-1-SOD fusion protein efficiently protects against paraquat-induced dopaminergic neuron damage in a Parkinson disease mouse model. Free Radical Biology and Medicine 41(7): 1058-1068

Kamwi, R.; Kenyon, T.; Newton, G. 2006: PEPFAR and HIV prevention in Africa. Lancet 367(9527): 1978-1979

Poole, L. 2001: PEPP: collaborating to improve quality. Journal of Ahima 72(4): 43-47

Barnatskiĭ, V.V.; Grigor'eva, V.D.; Pershin, S.B.; Derevnina, N.A.; Gontar', E.B. 2005: Influence of combined rehabilitation treatment including novel non-pharmacological technologies on immune system of patients with seronegetive spondylarthritis. Voprosy Kurortologii Fizioterapii i Lechebnoi Fizicheskoi Kultury 13(2): 20-24

Anonymous 1954: PEPTIC esophagitis. Journal of the American Medical Association 156(9): 893-894

Anonymous 1952: PEPTIC ulcer. Public Health 66(1): 1-3

Morgan 1953: Dumb-bell neurofibroma. Medical Journal of Australia 1(9): 318-319

Anonymous 1958: PEPTIC ulcer and secretor status. British Medical Journal 2(5099): 787-788

Anonymous 1959: PEPTIC ulcer in Africans. British Medical Journal 1(5135): 1462-1463

Cichocki, F.; Wu, C-Ying.; Zhang, B.; Felices, M.; Tesi, B.; Tuininga, K.; Dougherty, P.; Taras, E.; Hinderlie, P.; Blazar, B.R.; Bryceson, Y.T.; Miller, J.S. 2018: ARID5B regulates metabolic programming in human adaptive NK cells. Journal of Experimental Medicine 215(9): 2379-2395

Anonymous 1959: PEPTIC ulcer in infancy and childhood. British Medical Journal 1(5115): 160

Anonymous 1958: PEPTIC ulcer in twins. British Medical Journal 1(5085): 1470-1471

Wilson, H. 1951: Psychological factors in peptic ulceration. Medical World 75(5): 119-122

Haines, R.W. 1958: Arboreal or terrestrial ancestry of placental mammals. Quarterly Review of Biology 33(1): 1-23

Anonymous 1952: PEPTIC ulceration. Medical Press 228(15): 337-338

Anonymous 1957: PEPTIC ulceration and acid secretion. British Medical Journal 1(5022): 814-815

Shircore, J.O. 1952: The treatment of a protracted hiccough with intravenous atropine. East African Medical Journal 29(7): 272

Louw, J.H. 1956: The early diagnose of acute abdominal emergencies in infancy and early childhood. South African Medical Journal 30(35): 833-840

Anonymous 1956: PEPTIDES in casein synthesis. Nutrition Reviews 14(11): 348-349

Atlas, M. 2003: PER pressure: New Jersey's "Population Emissions Ratio" environmental equity screening model. Risk Analysis: An Official Publication of the Society for Risk Analysis 23(1): 69-79

Tato, M.; Valverde, A.án.; Coque, T.M.; Cantón, R. 2006: PER-1 multiresistant Pseudomonas aeruginosa strain in Spain. Enfermedades Infecciosas y Microbiologia Clinica 24(7): 472-473

Sechi, L.A.; Karadenizli, A.; Deriu, A.; Zanetti, S.; Kolayli, F.; Balikci, E.; Vahaboglu, H. 2004: PER-1 type beta-lactamase production in Acinetobacter baumannii is related to cell adhesion. Medical Science Monitor: International Medical Journal of Experimental and Clinical Research 10(6): Br180-Br184

Aktaş, Z.; Poirel, L.; Salcioğlu, M.; Ozcan, P.E.; Midilli, K.; Bal, C.; Anğ, O.; Nordmann, P. 2005: PER-1- and OXA-10-like beta-lactamases in ceftazidime-resistant Pseudomonas aeruginosa isolates from intensive care unit patients in Istanbul, Turkey. Clinical Microbiology and Infection: the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 11(3): 193-198

Anonymous 1950: PERCENT nonwhite: tuberculosis deaths and population by states, 1947. Public Health Reports 65(18): 610

Horton-Smith-Hartley, P. 1952: PERCIVAL Horton-Smith-Hartley. Lancet 2(6724): 95

Yearsley, P.M. 1951: PERCIVAL Macleod Yearsley. Lancet 1(6664): 1130

Ghent, P. 1952: PERCY Ghent R.T. Canadian Hospital 29(10): 16

Cardon, L.; Lemberg, L.; Greenebaum, R.S. 1951: Acute suppurative bronchitis and bronchiolitis in chronic pulmonary disease: diagnosis and management. Annals of Internal Medicine 34(3): 559-591

Tomlinson, P. 1951: PERCY Stanley Tomlinson. Lancet 1(6655): 643

Anonymous 1956: PERENNIAL copper and brass prove ruggedly enduring. Hospital Progress 37(2 Part 2): 388-394

Debre, R. 1951: Streptomycin. Maroc Medical 30(308): 3-5

De Moraes, D.J.; Abilio, F.M.; Cunha, M.; Feitosa, L.A..; Aragão, E.; Cysne, E.; Vieira, R.; Glavam, H.C.. C..; Zaniolo, W.; Netto, M.S.; Villela, R.D.A..; Labrunie, P. 1979: Perfusion for Myocardial Revascularization without an Artificial Oxygenator (New Method to Reduce Surgical Morbidity). Cardiovascular Diseases 6(2): 144-152

Behrman, S. 1952: Genesis of fetal abnormalities. Gp 6(2): 41-48

Anonymous 1953: PERICARDIAL effusion with surgical relief. American Practitioner and Digest of Treatment 4(7): 475-478

Mascher, W. 1951: Tuberculin-negative tuberculosis. American Review of Tuberculosis 63(5): 501-525

Anonymous 1955: PERILS of the patio. New England Journal of Medicine 253(1): 37-38

Anonymous 1958: PERINATAL mortality. Lancet 1(7021): 627-628

Anonymous 1950: PERINEAL care after delivery. American Journal of Nursing 50(6): 327

Anonymous 1953: PERINEAL speculum according to Prof. C.J. Gauss for speculum deliveries according to Bauereisen. Medizinische Technik 73(3): 63

Anonymous 1951: PERIOD of gestation. Lancet 1(6667): 1276

Riches, E.W. 1957: A standard diathermy cystoscope. British Medical Journal 2(5041): 407

Logan, W.P. 1953: Marriage and childbearing in relation to cancer of the breast and uterus. Lancet 265(6797): 1199-1202

Anonymous 1958: PERIPHERAL neuropathy and the lungs. British Medical Journal 2(5110): 1457-1458

Remouchamps 1951: Therapy of acute infections of the small intestine. Belgisch Tijdschrift Voor Geneeskunde 7(17): 769-772

Zivkovic, M.; Planinsek, F. 1952: The city of Novo Mesto. Higijena; Casopis Za Higijenu Mikrobiologiju Epidemiologiju i Sanitarnu Tehniku 4(6): 333-340

Detweiler, H.K. 1950: The psychogenic factor in asthma. Canadian Medical Association Journal 62(2): 128-130

Zeitlin, J.; Wildman, K.; Bréart, G.ér.; Alexander, S.; Barros, H.; Blondel, B.éa.; Buitendijk, S.; Gissler, M.; Macfarlane, A. 2003: PERISTAT: indicators for monitoring and evaluating perinatal health in Europe. European Journal of Public Health 13(3 Suppl): 29-37

Liang, S.-H.; Zhang, W.; McGrath, B.C.; Zhang, P.; Cavener, D.R. 2006: PERK (eIF2alpha kinase) is required to activate the stress-activated MAPKs and induce the expression of immediate-early genes upon disruption of ER calcium homoeostasis. Biochemical Journal 393(Part 1): 201-209

Hamanaka, R.B.; Bennett, B.S.; Cullinan, S.B.; Diehl, J.Alan. 2005: PERK and GCN2 contribute to eIF2alpha phosphorylation and cell cycle arrest after activation of the unfolded protein response pathway. Molecular Biology of the Cell 16(12): 5493-5501

Montie, H.L.; Haezebrouck, A.J.; Gutwald, J.C.; DeGracia, D.J. 2005: PERK is activated differentially in peripheral organs following cardiac arrest and resuscitation. Resuscitation 66(3): 379-389

Owen, C.R.; Kumar, R.; Zhang, P.; McGrath, B.C.; Cavener, D.R.; Krause, G.S. 2005: PERK is responsible for the increased phosphorylation of eIF2alpha and the severe inhibition of protein synthesis after transient global brain ischemia. Journal of Neurochemistry 94(5): 1235-1242

Youngquist, C.R. 1949: Morale-lifting reorganization that earns full medical staff support. Hospitals 23(11): 35-39

Anonymous 1952: PERMANENTE Plan's first ten years. New England Journal of Medicine 247(18): 692-693

Anonymous 1956: PERMEABILITY of the intestinal tract to unaltered proteins after infantile diarrhea. Nutrition Reviews 14(5): 137-138

Anonymous 1959: PERMISSIBLE concentrations of poisonous gases, vapors and dusts in the air of work shops. Gigiena i Sanitariia 24: 90-92

Anonymous 1952: PERNICIOUS anaemia and the ruby crystals; the story of vitamin B12. Cyprus Medical Journal 5(7): 850-853

Oatway, W.H. 1956: Hazards to unrecognized tuberculosis. Medical Times 84(11): 1170-1173

Raska, K. 1953: Infectious hepatitis. Casopis Lekaru Ceskych 92(13): 331-339

Anonymous 1951: PERNICIOUS anemia and multivitamin preparations. New England Journal of Medicine 245(14): 545-547

Anonymous 1952: PERNICIOUS anemia in childhood. Nutrition Reviews 10(4): 113-114

Anonymous 1955: PERNICIOUS anemia in relapse. Postgraduate Medicine 17(3): 20-21

Thomas, C.B. 1952: The heritage of hypertension. American Journal of the Medical Sciences 224(4): 367-376

Anonymous 1959: PERORAL mucosal biopsy of the small intestine. Il Policlinico. Sezione Pratica 66: 1393-1395

Goldsmith, P.G. 1951: PERRY Gladstone Goldsmith. Transactions - American Academy of Ophthalmology and Otolaryngology. American Academy of Ophthalmology and Otolaryngology 55: 737-738

Lauterer, Z. 1951: Principles of Pavlov's theory on the higher nervous system. Lekarske Listy 6(5): 129-136

Goldsmith, P.GLADSTONE. 1952: PERRY Gladstone Goldsmith, M.D., 1872-1951. Transactions of the .. Annual Meeting of the American Laryngological Association. American Laryngological Association. Annual Meeting 53(72nd Meeting): 229

Anonymous 1960: PERSISTENCE of immunity. British Medical Journal 1(5184): 1488-1489

Anonymous 1952: PERSISTENT hiccups. Lancet 2(6748): 1262

Goldie, H.; Felix, M.D. 1951: Growth characteristics of free tumor cells transferred serially in the peritoneal fluid of the mouse. Cancer Research 11(2): 73-80

Kenny, D.A. 2004: PERSON: a general model of interpersonal perception. Personality and Social Psychology Review: An Official Journal of the Society for Personality and Social Psychology Inc 8(3): 265-280

Anonymous 1959: PERSONAL consumption expenditures for medical care. Public Health Reports 74(3): 210-211

Federn, P. 1950: PERSONAL notes on Paul Federn. American Journal of PsychoTherapy 4(3): 503-516

Buxton, J.T. 1952: PERSONAL tribute to Dr. Joseph T. Buxton, founder of the Elizabeth Buxton Hospital. Virginia Medical Monthly 79(8): 460

Anonymous 1952: PERSONALITY alterations in undernutrition. Nutrition Reviews 10(11): 331-333

Anonymous 1956: PERSONALITY and cancer. British Medical Journal 1(4982): 1537

Duff, G.L. 1951: The pathogenesis of atherosclerosis. Canadian Medical Association Journal 64(5): 387-394

Rankin, R.M. 1951: Treatment of cerebrovascular accident. Physical Therapy Review 31(3): 81-84

Anonymous 1959: PERSONNEL positions and apprenticeships in 1960. Svensk Farmaceutisk Tidskrift 63: 929-935

Nocka, P.F. 1951: Bumper standardization would help reduce transport damage. Hospitals 25(11): 118-120

Anonymous 1955: PERSONNEL research produces scientific operating level. Hospital Progress 36(4): 57-59

Anonymous 1952: PERSPECTIVE on fluid administration. Journal of the National Medical Association 44(3): 220-224

Anonymous 2004: PERSUADE...(a EUROPA sub-study)...results: perindopril protects diabetic patients with coronary disease from cardiovascular death and heart attacks. Cardiovascular journal of South Africa: official journal for Southern Africa Cardiac Society and South African Society of Cardiac Practitioners 15(3): 146

Penn, R. 1951: Acceptable methods of fixing charges. Modern Hospital 76(3): 88-89

Anonymous 1951: PERTH Royal Infirmary. Nursing Mirror and Midwives Journal 92(2395): iv

Anonymous 1950: PERTINENT AOA resolutions. Optometric Weekly 41(28): 1064-1065

Cooper, D.K.; Buhler, L.H.; Kobayashi, T. 2006: PERV Methodology. Xenotransplantation 13(3): 171

Anonymous 1954: PERVERSION: theoretical and therapeutic aspects. Journal of the American Psychoanalytic Association 2(2): 336-345

Nudelman, G.; Tennenbaum, T.; Mehr, R.; Unger, R. 2002: PESI--an intelligent system for prediction of enzyme-substrate interactions based on experimental constraints. In Silico Biology 2(4): 495-505

Takano, A.; Suhara, T. 2006: PET (positron emission tomography) research on schizophrenia. Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica 128(3): 177-183

Kell, M.R.; Ridge, J.A.; Joseph, N.; Sigurdson, E.R. 2007: PET CT imaging in patients undergoing sentinel node biopsy for melanoma. European Journal of Surgical Oncology: the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 33(7): 911-913

Bolcák, K. 2005: PET Center - Masaryk Memorial Cancer Institute, Brno, Czech Republic. Nuclear Medicine Review. Central and Eastern Europe 8(2): 160-162

Cabrera Villegas, A. 2006: PET Group of the SEMN (Spanish Society of Nuclear Medicine): continuity of the pathway. Revista espanola de medicina nuclear 25(3): 157-158

Zhou, J.; Shu, H.; Xia, T.; Luo, L. 2005: PET Image Reconstruction Using Mumford-Shah Regularization Coupled with L1Data Fitting. Conference Proceedings: . Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual Conference 2005: 1905-1908

Xiangsong, Z.; Changhong, L.; Weian, C.; Dong, Z. 2006: PET Imaging of cerebral astrocytoma with 13N-ammonia. Journal of Neuro-Oncology 78(2): 145-151

Lacy, J.L..; Haynes, N.G..; Nayak, N.; Mathias, C.J..; Wallhaus, T.R..; Stewart, R.; Bianco, J.; Stone, C.K..; Green, M.A.. 1999: PET Myocardial Perfusion Imaging with Generator Produced Radiopharmaceuticals. 62Cu-PTSM and 62Cu-ETS. Clinical Positron Imaging: Official Journal of the Institute for Clinical P.E.T 2(6): 317

Nemoto, E.M.; Yonas, H.; Pindzola, R.R.; Kuwabara, H.; Sashin, D.; Chang, Y.; Jovin, T. 2007: PET OEF reactivity for hemodynamic compromise in occlusive vascular disease. Journal of Neuroimaging: Official Journal of the American Society of Neuroimaging 17(1): 54-60

Fornito, M.C. 2004: PET Scan in the work-up of NSCLC. I Suppli di Tumori: Official Journal of Societa Italiana di Cancerologia . 3(2): S21-S24

Nguyen, A.T..; Akhurst, T.; Larson, S.M..; Coit, D.G..; Brady, M.S.. 1999: PET Scanning with (18)F 2-Fluoro-2-Deoxy-D-Glucose (FDG) in Patients with Melanoma. Benefits and Limitations. Clinical Positron Imaging: Official Journal of the Institute for Clinical P.E.T 2(2): 93-98

Fowler, J.S..; Wang, G.J.; Volkow, N.D..; Ieni, J.; Logan, J.; Pappas, N.; Dewey, S.L.. 1999: PET Studies of the Effect of the Antidepressant Drugs Nefazodone or Paroxetine on [11C]Raclopride Binding in Human Brain. Clinical Positron Imaging: Official Journal of the Institute for Clinical P.E.T 2(4): 205-209

O'Neill, J.O.; McCarthy, P.M.; Brunken, R.C.; Buda, T.; Hoercher, K.; Young, J.B.; Starling, R.C. 2004: PET abnormalities in patients with nonischemic cardiomyopathy. Journal of Cardiac Failure 10(3): 244-249

Vanlancker-Sidtis, D.; McIntosh, A.R.; Grafton, S. 2003: PET activation studies comparing two speech tasks widely used in surgical mapping. Brain and Language 85(2): 245-261

De Wilde, V.; Vandenbroucke, F.; Neyns, B.; Everaert, H.; Demey, J. 2006: PET and CT demonstration of metastatic invasion of the thoracic duct. European Journal of Nuclear Medicine and Molecular Imaging 33(3): 392

May, A.; Weiller, C. 1996: PET and Doppler sonography in headaches. Schmerz 10(3): 140-145

Chisin, R.; Klein, M.; Freedman, N.; Mishani, E.; Shiloni, E.; Gimon, Z.; Lotem, M. 1998: PET and Lymphoscintigraphic Evaluation of Malignant Melanomas. the Hadassah Hospital Experience. Clinical Positron Imaging: Official Journal of the Institute for Clinical P.E.T 1(4): 252

Fanti, S.; Franchi, R.; Battista, G.; Monetti, N.; Canini, R. 2005: PET and PET-CT. State of the art and future prospects. La Radiologia Medica 110(1-2): 1-15

Brepoels, L.; Stroobants, S.; Verhoef, G. 2007: PET and PET/CT for response evaluation in lymphoma: current practice and developments. Leukemia and Lymphoma 48(2): 270-282

Reske, S.N.; Blumstein, N.M.; Glatting, G. 2006: PET and PET/CT in relapsing prostate carcinoma. Der Urologe. Ausg. a 45(10): 1240; 1242-1244; 1246-1248, 1250

Krause, B.J.; Beck, R.; Souvatzoglou, M.; Piert, M. 2006: PET and PET/CT studies of tumor tissue oxygenation. Quarterly Journal of Nuclear Medicine and Molecular Imaging: Official Publication of the Italian Association of Nuclear Medicine and the International Association of Radiopharmacology and Section of the Society Of. 50(1): 28-43

Endo, K.; Oriuchi, N.; Higuchi, T.; Iida, Y.; Hanaoka, H.; Miyakubo, M.; Ishikita, T.; Koyama, K. 2006: PET and PET/CT using 18F-FDG in the diagnosis and management of cancer patients. International Journal of Clinical Oncology 11(4): 286-296

Patel, M. 2003: PET and PET/CT: market outlook. Journal of Nuclear Medicine: Official Publication Society of Nuclear Medicine 44(7): 28n-29n

Lin, C.S.; Herman, C. 2003: The U.S. FDA's involvement in the development and utilization of D11.40's standards on rubber consumer products. Standardization News: Sn 31(7): 38-41

Guilloteau, D.; Chalon, S. 2005: PET and SPECT exploration of central monoaminergic transporters for the development of new drugs and treatments in brain disorders. Current Pharmaceutical Design 11(25): 3237-3245

Soyka, M.; Dresel, S.; Horak, M.; Rüther, T.; Tatsch, K. 2000: PET and SPECT findings in alcohol hallucinosis: case report and super-brief review of the pathophysiology of this syndrome. World Journal of Biological Psychiatry: the Official Journal of the World Federation of Societies of Biological Psychiatry 1(4): 215-218

Henze, M.; Mohammed, A.; Schlemmer, H.P.; Herfarth, K.K.; Hoffner, S.; Haufe, S.; Mier, W.; Eisenhut, M.; Debus, J.ür.; Haberkorn, U. 2004: PET and SPECT for detection of tumor progression in irradiated low-grade astrocytoma: a receiver-operating-characteristic analysis. Journal of Nuclear Medicine: Official Publication Society of Nuclear Medicine 45(4): 579-586

Antonini, A.; DeNotaris, R. 2004: PET and SPECT functional imaging in Parkinson's disease. Sleep Medicine 5(2): 201-206

Tatsch, K.; Ell, P.J. 2006: PET and SPECT in common neuropsychiatric disease. Clinical Medicine 6(3): 259-262

Mena, J.C.; Cuellar, H.; Vargas, D.; Riascos, R. 2005: PET and SPECT in drug and substance abuse. Topics in Magnetic Resonance Imaging: Tmri 16(3): 253-256

Minn, H. 2005: PET and SPECT in low-grade glioma. European Journal of Radiology 56(2): 171-178

Asenbaum, S. 2003: PET and SPECT investigations in Alzheimer's disease. Der Radiologe 43(7): 521-530

Catafau, A.M.; Semih Dogan, A. 2003: PET and SPECT of cerebral neurotransmission. Revista Espanola de Medicina Nuclear 22(2): 109-121

Cheow, H.K.; Mikhaeel, N.G.; O'Doherty, M.J. 2006: PET and TNM: evolution or revolution?. Nuclear Medicine Communications 27(2): 101-103

Yasuda, S.; Ide, M. 2005: PET and cancer screening. Annals of Nuclear Medicine 19(3): 167-177

Någren, K. 2003: PET and knockout mice in drug discovery. Drug Discovery Today 8(19): 876

Talbot, J.-N.ël.; Kerrou, K.; Gault, N.; Gutman, F.; Grahek, D.; Touboul, E.; Schlienger, M.; Montravers, F.ço. 2006: PET and malignant cerebral tumors. Presse Medicale 35(9 Part 2): 1347-1353

Ito, M.; Yang, D.J.; Mawlawi, O.; Mendez, R.; Oh, C.-S.; Azhdarinia, A.; Greenwell, A.C.; Yu, D.-F.; Kim, E.E. 2006: PET and planar imaging of tumor hypoxia with labeled metronidazole. Academic Radiology 13(5): 598-609

Reske, S.N. 2003: PET and restaging of malignant lymphoma including residual masses and relapse. European Journal of Nuclear Medicine and Molecular Imaging 30(Suppl 1): S89-S96

Pietrini, P.; Teipel, S.J.; Bartenstein, P.; Rapoport, S.I.; Möller, H.J.; Hampel, H. 1998: PET and the effects of aging and neurodegeneration on brain function: basic principles. Drug News and Perspectives 11(3): 161-165

Pither, R. 2003: PET and the role of in vivo molecular imaging in personalized medicine. Expert Review of Molecular Diagnostics 3(6): 703-713

García, J.é; Simó, M.; Castell, J. 2005: PET assessment of myocardial viability following AMI. Significance of reverse mismatch pattern. Revista Espanola de Cardiologia 58(11): 1364-1365

Reivich, M.; Amsterdam, J.D.; Brunswick, D.J.; Shiue, C.Y. 2004: PET brain imaging with [11C](+)McN5652 shows increased serotonin transporter availability in major depression. Journal of Affective Disorders 82(2): 321-327

Mulaik, M.W. 2005: PET coding. Radiology Management 27(3): 42-43

Zimmermann, M.; Lüthi, F.ço.; Zouhair, A.; Ketterer, N.; Prior, J.O.; Kamel, M.E.; Bischof-Delaloye, A. 2005: PET contribution in oncology. Revue Medicale Suisse 1(20): 1335-1338; 1341-1342

Nguyen, B.D. 2005: PET demonstration of left atrial appendage in chronic atrial fibrillation. Clinical Nuclear Medicine 30(3): 177-179

Cózar, M.P.; Ortega, F.; Fuster, C.; Vázquez-Albadalejo, C.; Santos, J.; Almenar, S. 2006: PET detection of a primary gall bladder tumor and pericystic metastatic adenopathy. Revista Espanola de Medicina Nuclear 25(2): 113-114

Wagner, J.D. 2003: PET detection of melanoma metastases in lymph nodes. Journal of Nuclear Medicine: Official Publication Society of Nuclear Medicine 44(3): 486

Wu, G.; Bybel, B.; Brunken, R.; Lin, H.; Neumann, D. 2005: PET detection of solitary distant skeletal muscle metastasis of esophageal adenocarcinoma. Clinical Nuclear Medicine 30(5): 335-337

Suzuki, R.; Watanabe, H.; Yanagawa, T.; Sato, J.; Shinozaki, T.; Suzuki, H.; Endo, K.; Takagishi, K. 2005: PET evaluation of fatty tumors in the extremity: possibility of using the standardized uptake value (SUV) to differentiate benign tumors from liposarcoma. Annals of Nuclear Medicine 19(8): 661-670

Nakagawa, M.; Kuwabara, Y.; Taniwaki, T.; Sasaki, M.; Koga, H.; Kaneko, K.; Hayashi, K.; Kira, J.-i.; Honda, H. 2005: PET evaluation of the relationship between D2 receptor binding and glucose metabolism in patients with parkinsonism. Annals of Nuclear Medicine 19(4): 267-275

Bender, D.; Olsen, A.K.; Marthi, M.K.; Smith, D.F.; Cumming, P. 2004: PET evaluation of the uptake of N-[11C]methyl CP-643,051, an NK1 receptor antagonist, in the living porcine brain. Nuclear Medicine and Biology 31(6): 699-704

Lee, J.S.; Lee, D.S.; Oh, S.H.; Kim, C.S.; Kim, J.-W.; Hwang, C.H.; Koo, J.; Kang, E.; Chung, J.-K.; Lee, M.C. 2003: PET evidence of neuroplasticity in adult auditory cortex of postlingual deafness. Journal of Nuclear Medicine: Official Publication Society of Nuclear Medicine 44(9): 1435-1439

Stelzner, F.; Ruhlmann, J. 2003: PET examination of metastases of somatic carcinomas via the lymphatic system (thyroid gland and breast). Der Chirurg; Zeitschrift für Alle Gebiete der Operativen Medizen 74(2): 118-124

Gil Martínez, E.M.; Galera Ruiz, H.; Moya García, F.; González Cabezas, P. 2006: PET finding of primary tonsilar cancer in a man with unknown tumor. Revista Espanola de Medicina Nuclear 25(4): 263-264

Moore, W.; Franceschi, D. 2005: PET findings in pulmonary dirofilariasis. Journal of Thoracic Imaging 20(4): 305-306

Halldin, C.; Gulyás, B.; Farde, L. 2004: PET for drug development. Ernst Schering Research Foundation Workshop 48: 95-109

Klem, M.L.; Grewal, R.K.; Wexler, L.H.; Schöder, H.; Meyers, P.A.; Wolden, S.L. 2007: PET for staging in rhabdomyosarcoma: an evaluation of PET as an adjunct to current staging tools. Journal of Pediatric Hematology/Oncology 29(1): 9-14

Schiepers, C.; Filmont, J.-E.; Czernin, J. 2003: PET for staging of Hodgkin's disease and non-Hodgkin's lymphoma. European Journal of Nuclear Medicine and Molecular Imaging 30(Suppl 1): S82-S88

Ncayiyana, D.J. 2004: The looming threat of HIV/AIDS drug resistance in South Africa. South African Medical Journal 94(8): 1 P Preceding 590

Esik, O.; Emri, M.ós.; Szakáll, S.; Herzog, H.; Sáfrány, G.éz.; Lengyel, E.éb.; Boér, A.ás.; Liszkay, G.; Trón, L.; Lengyel, Z.; Repa, I. 2004: PET identifies transitional metabolic change in the spinal cord following a subthreshold dose of irradiation. Pathology Oncology Research: Por 10(1): 42-46

Liu, H.; Tian, Y.; Shi, P. 2005: PET image reconstruction: a robust state space approach. Information Processing in Medical Imaging: Proceedings of the . Conference 19: 197-209

Alavi, A. 2004: PET imaging I. Radiologic Clinics of North America 42(6): Xi-Xiii

Visvanathan, R. 2003: PET imaging and dementia. Medical Science Monitor: International Medical Journal of Experimental and Clinical Research 9(4): Ra76-Ra80

Hustinx, R.; Pourdehnad, M.; Kaschten, B.; Alavi, A. 2005: PET imaging for differentiating recurrent brain tumor from radiation necrosis. Radiologic Clinics of North America 43(1): 35-47

Erturk, S.M.; Ichikawa, T.; Fujii, H.; Yasuda, S.; Ros, P.R. 2006: PET imaging for evaluation of metastatic colorectal cancer of the liver. European Journal of Radiology 58(2): 229-235

Roberts, K.B.; Manus, M.P.M.; Hicks, R.J.; Rischin, D.; Wirth, A.; Wright, G.M.; Ball, D.L. 2005: PET imaging for suspected residual tumour or thoracic recurrence of non-small cell lung cancer after pneumonectomy. Lung Cancer 47(1): 49-57

Hustinx, R. 2004: PET imaging in assessing gastrointestinal tumors. Radiologic Clinics of North America 42(6): 1123-1139 Ix

Chacko, G.N. 2005: PET imaging in cardiology. Hellenic Journal of Nuclear Medicine 8(3): 140-144

Gatley, S.J.; Volkow, N.D.; Wang, G.-J.; Fowler, J.S.; Logan, J.; Ding, Y.-S.; Gerasimov, M. 2005: PET imaging in clinical drug abuse research. Current Pharmaceutical Design 11(25): 3203-3219

Kumar, R.; Alavi, A. 2004: PET imaging in gynecologic malignancies. Radiologic Clinics of North America 42(6): 1155-1167 Ix

Kimura, T. 2004: PET imaging in patients with neurogenic pain. Masui. Japanese Journal of Anesthesiology 53 Suppl: S176-S182

Hudson, M.M.; Krasin, M.J.; Kaste, S.C. 2004: PET imaging in pediatric Hodgkin's lymphoma. Pediatric Radiology 34(3): 190-198

Shulkin, B.L. 2004: PET imaging in pediatric oncology. Pediatric Radiology 34(3): 199-204

Schelbert, H.R.; Inubushi, M.; Ross, R.S. 2003: PET imaging in small animals. Journal of Nuclear Cardiology: Official Publication of the American Society of Nuclear Cardiology 10(5): 513-520

Silverman, D.H.S.; Alavi, A. 2005: PET imaging in the assessment of normal and impaired cognitive function. Radiologic Clinics of North America 43(1): 67-77 X

Scheffel, U.; Pomper, M.G. 2004: PET imaging of GRP receptor expression in prostate cancer. Journal of Nuclear Medicine: Official Publication Society of Nuclear Medicine 45(8): 1277-1278

Nguyen, B.D. 2003: PET imaging of Sertoli cell tumor in androgen insensitivity syndrome. Clinical Nuclear Medicine 28(9): 743-745

Nordberg, A. 2004: PET imaging of amyloid in Alzheimer's disease. Lancet. Neurology 3(9): 519-527

Cauchon, N.; Langlois, R.éj.; Rousseau, J.A.; Tessier, G.; Cadorette, J.; Lecomte, R.; Hunting, D.J.; Pavan, R.A.; Zeisler, S.K.; van Lier, J.E. 2007: PET imaging of apoptosis with (64)Cu-labeled streptavidin following pretargeting of phosphatidylserine with biotinylated annexin-V. European Journal of Nuclear Medicine and Molecular Imaging 34(2): 247-258

Tipre, D.N.; Zoghbi, S.S.; Liow, J.-S.; Green, M.V.; Seidel, J.; Ichise, M.; Innis, R.B.; Pike, V.W. 2006: PET imaging of brain 5-HT1A receptors in rat in vivo with 18F-FCWAY and improvement by successful inhibition of radioligand defluorination with miconazole. Journal of Nuclear Medicine: Official Publication Society of Nuclear Medicine 47(2): 345-353

Liu, R.-S.; Chang, C.-P.; Chu, L.-S.; Chu, Y.-K.; Hsieh, H.-J.; Chang, C.-W.; Yang, B.-H.; Yen, S.-H.; Huang, M.-C.; Liao, S.-Q.; Yeh, S.-H. 2006: PET imaging of brain astrocytoma with 1-11C-acetate. European Journal of Nuclear Medicine and Molecular Imaging 33(4): 420-427

Toyama, H.; Ye, D.; Ichise, M.; Liow, J.-S.; Cai, L.; Jacobowitz, D.; Musachio, J.L.; Hong, J.; Crescenzo, M.; Tipre, D.; Lu, J.-Q.; Zoghbi, S.; Vines, D.C.; Seidel, J.; Katada, K.; Green, M.V.; Pike, V.W.; Cohen, R.M.; Innis, R.B. 2005: PET imaging of brain with the beta-amyloid probe, [11C]6-OH-BTA-1, in a transgenic mouse model of Alzheimer's disease. European Journal of Nuclear Medicine and Molecular Imaging 32(5): 593-600

Mankoff, D.A.; Shields, A.F.; Krohn, K.A. 2005: PET imaging of cellular proliferation. Radiologic Clinics of North America 43(1): 153-167

Mascarenhas, N.B.; Lam, D.; Lynch, G.R.; Fisher, R.E. 2006: PET imaging of cerebral and pulmonary Nocardia infection. Clinical Nuclear Medicine 31(3): 131-133

Nguyen, B.D. 2005: PET imaging of concomitant colonic hyperplastic polyp and tubulovillous adenoma. Clinical Nuclear Medicine 30(1): 48-50

Kadir, A.; Almkvist, O.; Wall, A.; Långström, B.; Nordberg, A. 2006: PET imaging of cortical 11C-nicotine binding correlates with the cognitive function of attention in Alzheimer's disease. Psychopharmacology 188(4): 509-520

Chander, S.; Lee, P.; Zingas, A.P.; Joyrich, R.N.; Zak, I.T.; Bloom, D.A. 2005: PET imaging of gallbladder carcinoma. Clinical Nuclear Medicine 30(12): 804-805

Ding, Y.-S.; Lin, K.-S.; Logan, J. 2006: PET imaging of norepinephrine transporters. Current Pharmaceutical Design 12(30): 3831-3845

Dimitrakopoulou-Strauss, A.; Strauss, L.G. 2003: PET imaging of prostate cancer with 11C-acetate. Journal of Nuclear Medicine: Official Publication Society of Nuclear Medicine 44(4): 556-558

Jones, H.A.; Boobis, A.R.; Hamacher, K.; Coenen, H.H.; Clark, J.C. 2003: PET imaging of pulmonary fibrosis. Journal of Nuclear Medicine: Official Publication Society of Nuclear Medicine 44(3): 483-4; Author Reply 484

Padhani, A. 2006: PET imaging of tumour hypoxia. Cancer Imaging: the Official Publication of the International Cancer Imaging Society 6: S117-S121

Sattar, T.; Griffeth, L.K.; Latifi, H.R.; Glass, J.; Munker, R.; Lilien, D.L. 2006: PET imaging today: contribution to the initial staging and prognosis of patients with non-Hodgkin's lymphomas. Journal of the Louisiana State Medical Society: Official Organ of the Louisiana State Medical Society 158(4): 193-201

Shields, A.F. 2003: PET imaging with 18F-FLT and thymidine analogs: promise and pitfalls. Journal of Nuclear Medicine: Official Publication Society of Nuclear Medicine 44(9): 1432-1434

Park, Y.H.; Choi, S.-J.; Ryoo, B.-Y.; Kim, H.T. 2005: PET imaging with F-18 fluorodeoxyglucose for primary lymphoma of bone. Clinical Nuclear Medicine 30(2): 131-134

Wieder, H.A.; Geinitz, H.; Rosenberg, R.; Lordick, F.; Becker, K.; Stahl, A.; Rummeny, E.; Siewert, J.ör.R.; Schwaiger, M.; Stollfuss, J. 2007: PET imaging with [18F]3'-deoxy-3'-fluorothymidine for prediction of response to neoadjuvant treatment in patients with rectal cancer. European Journal of Nuclear Medicine and Molecular Imaging 34(6): 878-883

Buchholz, H.G.; Herzog, H.; Förster, G.J.; Reber, H.; Nickel, O.; Rösch, F.; Bartenstein, P. 2003: PET imaging with yttrium-86: comparison of phantom measurements acquired with different PET scanners before and after applying background subtraction. European Journal of Nuclear Medicine and Molecular Imaging 30(5): 716-720

Lee, Z.; Berridge, M.S. 2002: PET imaging-based evaluation of aerosol drugs and their delivery devices: nasal and pulmonary studies. IEEE Transactions on Medical Imaging 21(10): 1324-1331

Foehrenbach, H. 2003: PET imaging: an update from RSNA 2002. Journal de Radiologie 84(7-8 Pt 1): 761-765

Cohen, P.F..; Sossi, V.; Johnson, R.R..; Ruth, T. 1999: PET in Canada. Historical Perspectives, Current Status, Challenges to Future Growth. Clinical Positron Imaging: Official Journal of the Institute for Clinical P.E.T 2(6): 345

Sánchez Salmón, A.; Barandela Salgado, J.; Ruibal Morell, A. 2006: PET in abdominal pathology: advantages and limitations. Abdominal Imaging 31(2): 174-181

Takalkar, A.; Mavi, A.; Alavi, A.; Araujo, L. 2005: PET in cardiology. Radiologic Clinics of North America 43(1): 107-19 Xi

Rankin, S.C. 2006: PET in face and neck tumours. Cancer Imaging: the Official Publication of the International Cancer Imaging Society 6: S89-S95

Talbot, J.-N.ël.; Périé, S.; Kerrou, K.; Montravers, F.ço.; Balogova, S.; Grahek, D.; Gutman, F.; Saint Guily, J.L. 2006: PET in head and neck cancers. Presse Medicale 35(9 Part 2): 1355-1369

Collins, C.D. 2006: PET in lymphoma. Cancer Imaging: the Official Publication of the International Cancer Imaging Society 6: S63-S70

Hoskin, P.J. 2003: PET in lymphoma: what are the oncologist's needs?. European Journal of Nuclear Medicine and Molecular Imaging 30(Suppl 1): S37-S41

Carreras Delgado, J.é L. 2004: PET in lymphomas: a pattern for the treatment at measure. Anales de la Real Academia Nacional de Medicina 121(4): 739-750

Khandani, A.H.; Fielding, J.R. 2007: PET in management of small pulmonary nodules. Radiology 242(3): 948-9; author reply 949

Bartenstein, P. 2004: PET in neuroscience: dopaminergic, GABA/benzodiazepine, and opiate system. NUKLEARMEDIZIN. Nuclear Medicine 43(1): 33-42

Jadvar, H.; Alavi, A.; Mavi, A.; Shulkin, B.L. 2005: PET in pediatric diseases. Radiologic Clinics of North America 43(1): 135-152

Talbot, J.-N.ël.; Kerrou, K.; Grahek, D.; Balogova, S.; Gounant, V.ér.; Lavole, A.; Gutman, F.; Aflalo-Hazan, V.; Raileanu, I.; Montravers, F.ço.; Mayaud, C. 2006: PET in primary pulmonary or pleural cancer. Presse Medicale 35(9 Part 2): 1387-1400

Newberg, A.B.; Alavi, A. 2005: PET in seizure disorders. Radiologic Clinics of North America 43(1): 79-92

Sundin, A.; Eriksson, B.; Bergström, M.; Långström, B.; Oberg, K.; Orlefors, H.åk. 2004: PET in the diagnosis of neuroendocrine tumors. Annals of the new York Academy of Sciences 1014: 246-257

Khan, N.; Oriuchi, N.; Higuchi, T.; Zhang, H.; Endo, K. 2003: PET in the follow-up of differentiated thyroid cancer. British Journal of Radiology 76(910): 690-695

Siegel, C. 2005: PET in the management of urologic malignancies. Journal of Urology 174(4 Part 1): 1252

Talbot, J.-N.ël.; Montravers, F.ço.; Younsi, N.; Zanotti-Fregonara, P.; Zanotti, P.; Grahek, D.; Kerrou, K.; Gutman, F.; Périé, S.; Maurel, G.ér.; Saint Guily, J.L.; Devaux, J.-Y.; Duron, F.ço. 2006: PET in thyroid cancers. Presse Medicale 35(9 Part 2): 1377-1385

Surti, S.; Karp, J.S.; Kinahan, P.E. 2004: PET instrumentation. Radiologic Clinics of North America 42(6): 1003-16 Vii

Hattori, N.; Huang, S.C.; Wu, H.M.; Liao, W.; Glenn, T.C.; Vespa, P.M.; Phelps, M.E.; Hovda, D.A.; Bergsneider, M. 2003: PET investigation of post-traumatic cerebral blood volume and blood flow. Acta Neurochirurgica. Suppl 86: 49-52

Pupi, A.; Nobili, F.M. 2005: PET is better than perfusion SPECT for early diagnosis of Alzheimer's disease -- against. European Journal of Nuclear Medicine and Molecular Imaging 32(12): 1466-1472

Ishii, K.; Minoshima, S. 2005: PET is better than perfusion SPECT for early diagnosis of Alzheimer's disease -- for. European Journal of Nuclear Medicine and Molecular Imaging 32(12): 1463-1465

Watabe, H.; Ikoma, Y.; Kimura, Y.; Naganawa, M.; Shidahara, M. 2006: PET kinetic analysis--compartmental model. Annals of Nuclear Medicine 20(9): 583-588

Nojiri, T.; Nariai, T.; Aoyagi, M.; Ohno, K. 2005: PET measured 11C-methionine uptake correlates with proliferation capacity and microvascular density of cerebral glioma. Nihon Rinsho. Japanese Journal of Clinical Medicine 63(Suppl 9): 258-262

Ibaraki, M.; Shimosegawa, E.; Miura, S.; Takahashi, K.; Ito, H.; Kanno, I.; Hatazawa, J. 2004: PET measurements of CBF, OEF, and CMRO2 without arterial sampling in hyperacute ischemic stroke: method and error analysis. Annals of Nuclear Medicine 18(1): 35-44

Hall, M.J.; Allen, L.T.; O'Shea, D.F. 2006: PET modulated fluorescent sensing from the BF2 chelated azadipyrromethene platform. Organic and Biomolecular Chemistry 4(5): 776-780

Bacharach, S.L.; Bax, J.J.; Case, J.; Delbeke, D.; Kurdziel, K.A.; Martin, W.H.; Patterson, R.E. 2003: PET myocardial glucose metabolism and perfusion imaging: Part 1-Guidelines for data acquisition and patient preparation. Journal of Nuclear Cardiology: Official Publication of the American Society of Nuclear Cardiology 10(5): 543-556

Schelbert, H.R.; Beanlands, R.; Bengel, F.; Knuuti, J.; Dicarli, M.; Machac, J.; Patterson, R. 2003: PET myocardial perfusion and glucose metabolism imaging: Part 2-Guidelines for interpretation and reporting. Journal of Nuclear Cardiology: Official Publication of the American Society of Nuclear Cardiology 10(5): 557-571

Nariai, T.; Shimada, Y.; Ishiwata, K.; Nagaoka, T.; Shimada, J.; Kuroiwa, T.; Ono, K.I.; Hirakawa, K.; Senda, M.; Ohno, K. 2003: PET neuroreceptor imaging as predictor of severe cerebral ischemic insult. Acta Neurochirurgica. Suppl 86: 45-48

Peng, F.; Lu, X.; Janisse, J.; Muzik, O.; Shields, A.F. 2006: PET of human prostate cancer xenografts in mice with increased uptake of 64CuCl2. Journal of Nuclear Medicine: Official Publication Society of Nuclear Medicine 47(10): 1649-1652

Ostergaard, K. 2006: PET or SPECT for postsynaptic nerve cells in the striatum can possibly contribute to better insight to manganese-induced parkinsonism. Ugeskrift for laeger 168(6): 598-9; author reply 599-600

Grigg, A.; Ganju, V. 2006: PET positive progressive transformation of germinal centers masquerading as relapsed Hodgkin lymphoma post-autograft. Leukemia and Lymphoma 47(4): 764-765

Walker, R.C.; Zigler, S.S. 2003: PET practice in nuclear pharmacy. Journal of the American Pharmacists Association: Japha 43(5 Suppl 1: S42-S43

Xie, G.; Gunn, R.N.; Dagher, A.; Daloze, T.; Plourde, G.; Backman, S.B.; Diksic, M.; Fiset, P. 2004: PET quantification of muscarinic cholinergic receptors with [N-11C-methyl]-benztropine and application to studies of propofol-induced unconsciousness in healthy human volunteers. Synapse 51(2): 91-101

Reinhardt, M.J.; Wiethoelter, N.; Matthies, A.; Joe, A.Y.; Strunk, H.; Jaeger, U.; Biersack, H.-J. 2006: PET recognition of pulmonary metastases on PET/CT imaging: impact of attenuation-corrected and non-attenuation-corrected PET images. European Journal of Nuclear Medicine and Molecular Imaging 33(2): 134-139

Herschman, H.R. 2004: PET reporter genes for noninvasive imaging of gene therapy, cell tracking and transgenic analysis. Critical Reviews in Oncology/Hematology 51(3): 191-204

Anonymous 2006: PET scan best in chronic osteomyelitis diagnosis. Journal of Family Practice 55(3): 188

Egusquiza, D. 2001: APCs give PFS professionals a chance to manage outside the box. Patient Accounts 24(5): 2

Junginger, T. 2004: PET scan diagnosis of lymph node metastases of esophageal carcinoma. Der Chirurg; Zeitschrift für Alle Gebiete der Operativen Medizen 75(3): 312-3; Author Reply 313-4

Pagliai, F.; Rigacci, L.; Briganti, V.; Dini, C.; Castagnoli, A.; Vaggelli, L.; Bosi, A. 2003: PET scan evaluation of thymic mass after autologous peripheral blood stem-cell transplantation in an adult with non-Hodgkin's lymphoma. Leukemia and Lymphoma 44(11): 2015-2018

Varney, N.R.; Morrow, L.A.; Pinkston, J.B.; Wu, J.C. 1998: PET scan findings in a patient with a remote history of exposure to organic solvents. Applied Neuropsychology 5(2): 100-106

Kline, R.M. 2006: PET scan hypermetabolism induced by influenza vaccination in a patient with non-Hodgkin lymphoma. Pediatric Blood and Cancer 46(3): 389

Biering, H.; Pirlich, M.; Bauditz, J.; Sandrock, D.; Lochs, H.; Gerl, H. 2003: PET scan in occult ectopic ACTH syndrome: a useful tool?. Clinical Endocrinology 59(3): 404-405

Vansteenkiste, J.F. 2003: PET scan in the staging of non-small cell lung cancer. Lung Cancer 42(Suppl 1): S27-S37

Anonymous 2003: PET scan may offer tool for earlier diagnosis of AD. American Journal of Alzheimer's Disease and Other Dementias 18(6): 327-328

Lhommel, R.; Annet, L.; Bol, A.; Gigot, J-F.; Sempoux, C.; Mathieu, I.; Seret, M.; Lonneux, M. 2005: PET scan with 11C-acetate for the imaging of liver masses: report of a false positive case. European Journal of Nuclear Medicine and Molecular Imaging 32(5): 629

Kuhlman, J.E.; Perlman, S.B.; Weigel, T.; Collins, J.; Yandow, D.; Broderick, L.S. 2004: PET scan-CT correlation: what the chest radiologist needs to know. Current Problems in Diagnostic Radiology 33(4): 171-188

Tamara, L.; Tamara, C.; Velez, I. 2005: PET scan: a more definitive assessment modality for oral cancer. Today's Fda: Official Monthly Journal of the Florida Dental Association 17(5): 17-18

Chatziioannou, A.F. 2002: PET scanners dedicated to molecular imaging of small animal models. Molecular Imaging and Biology 4(1): 47-63

Berninger, V.W.; Abbott, R.D.; Zook, D.; Ogier, S.; Lemos-Britton, Z.; Brooksher, R. 2004: Early intervention for reading disabilities: teaching the alphabet principle in a connectionist framework. Journal of Learning Disabilities 32(6): 491-503

Sperling, M.A. 2007: PET scanning for infants with HHI: a small step for affected infants, a giant leap for the field. Journal of Pediatrics 150(2): 122-124

Mac Manus, M.P.; Hicks, R.J. 2003: PET scanning in lung cancer: current status and future directions. Seminars in Surgical Oncology 21(3): 149-155

Conybeare, A.; Waller, D.A. 2007: PET scanning in the detection of occult gastric metastases from lung carcinoma. European Journal of Surgical Oncology: the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 33(2): 252-253

Vaylet, F.; Bonardel, G.; Salles, Y.; Bonnichon, A.; Gontier, E.; Margery, J.; Mantzarides, M.; Guigay, J.; Foehrenbach, H. 2005: PET scanning in the initial assessment of lung cancer. Revue des Maladies Respiratoires 22(6 Part 2): 8s43-8s48

Whitaker, D.; Dussek, J. 2004: PET scanning in thymic neuroendocrine tumors. Chest 125(6): 2368-2369

Weber, F. 2006: PET scans and traumatic brain injuries: a brief comment. Aviation Space and Environmental Medicine 77(10): 1083

Edhayan, E.; Lloyd, L. 2004: PET scans in general surgery: current status in their use for general surgery. Current Surgery 61(3): 263-266

Friedberg, J.W.; Chengazi, V. 2003: PET scans in the staging of lymphoma: current status. Oncologist 8(5): 438-447

Kalish, J.A.; Babineau, T.J. 2006: PET scans in tumor staging: hope or hype?. Current Surgery 63(1): 8-12

Orrego, J.J.; Georgitis, W.J. 2003: Visual vignette. Bilateral adrenal calcifications. Endocrine Practice: Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 9(6): 572

Merrell, R.C. 2001: PET scans: Is it time to install these in community hospitals?. Current Surgery 58(6): 525-528

Fredriksson, A.; Stone-Elander, S. 2003: PET screening of anticancer drugs. a faster route to drug/target evaluations in vivo. Methods in Molecular Medicine 85: 279-294

Linazasoro, G.; Leenders, K.L. 2004: PET studies and physiopathology of motor fluctuations in Parkinson's disease. Brain: a journal of neurology 127(Pt 8): E15; author reply E16

Herholz, K. 2003: PET studies in dementia. Annals of Nuclear Medicine 17(2): 79-89

Shintani, S.; Tsuruoka, S.; Shiigai, T.; Ishii, K. 2003: PET study in bilateral internal carotid artery occlusion. Cerebrovascular Diseases 16(4): 442-447

Kumaran, R.; Ramamurthy, P. 2006: PET suppression of acridinedione dyes by urea derivatives in water and methanol. Journal of Physical Chemistry. B 110(47): 23783-23789

Amano, M. 2003: PET technology applied for FDG based examination--in consideration of the approval by the health insurance system--part 1. Nihon Hoshasen Gijutsu Gakkai Zasshi 59(1): 117-120

Amano, M. 2003: PET technology applied for FDG based examination--in consideration of the approval by the health insurance system-Part 2. Nihon Hoshasen Gijutsu Gakkai Zasshi 59(3): 398-399

Visvikis, D.; Cheze-Le Rest, C.; Jarritt, P. 2004: PET technology: current trends and future developments. British Journal of Radiology 77(923): 906-910

Hicks, R.J.; Dorow, D.; Roselt, P. 2006: PET tracer development--a tale of mice and men. Cancer Imaging: the Official Publication of the International Cancer Imaging Society 6: S102-S106

Reiman, R.E. 2004: PET tracers for osteosarcoma. Journal of Nuclear Medicine: Official Publication Society of Nuclear Medicine 45(8): 1424; Author Reply 1424-5

Debruyne, J.C.; Versijpt, J.; Van Laere, K.J.; De Vos, F.; Keppens, J.; Strijckmans, K.; Achten, E.; Slegers, G.; Dierckx, R.A.; Korf, J.; De Reuck, J.L. 2003: PET visualization of microglia in multiple sclerosis patients using [11C]PK11195. European Journal of Neurology 10(3): 257-264

Le Page, M. 2006: Only drugs can stop the sports cheats. New Scientist 191(2565): 18-19

Weber, W.A.; Dietlein, M.; Hellwig, D.; Kirsch, C.-M.; Schicha, H.; Schwaiger, M. 2003: PET with (18)F-fluorodeoxyglucose for staging of non-small cell lung cancer. NUKLEARMEDIZIN. Nuclear Medicine 42(4): 135-144

Lange-Nolde, A.; Zajic, T.; Slawik, M.; Brink, I.; Reincke, M.; Moser, E.; Hoegerle, S. 2006: PET with 18F-DOPA in the imaging of parathyroid adenoma in patients with primary hyperparathyroidism. a pilot study. NUKLEARMEDIZIN. Nuclear Medicine 45(5): 193-196

Mantaka, P.; Baum, R.P.; Hertel, A.; Adams, S.; Niessen, A.; Sengupta, S.; Hör, G. 2003: PET with 2-[F-18]-fluoro-2-deoxy-D-glucose (FDG) in patients with cancer of unknown primary (CUP): influence on patients' diagnostic and therapeutic management. Cancer BioTherapy and Radiopharmaceuticals 18(1): 47-58

Rini, J.N.; Bhargava, K.K.; Tronco, G.G.; Singer, C.; Caprioli, R.; Marwin, S.E.; Richardson, H.L.; Nichols, K.J.; Pugliese, P.V.; Palestro, C.J. 2006: PET with FDG-labeled leukocytes versus scintigraphy with 111In-oxine-labeled leukocytes for detection of infection. Radiology 238(3): 978-987

Pauleit, D.; Stoffels, G.; Schaden, W.; Hamacher, K.; Bauer, D.; Tellmann, L.; Herzog, H.; Bröer, S.; Coenen, H.H.; Langen, K.-J. 2005: PET with O-(2-18F-Fluoroethyl)-L-Tyrosine in peripheral tumors: first clinical results. Journal of Nuclear Medicine: Official Publication Society of Nuclear Medicine 46(3): 411-416

Bergström, M.; Sörensen, J.; Kahn, T.S..; Juhlin, C.; Eriksson, B.; Sundin, A.; Bonasera, T.A..; Fasth, K.-J..; Långström, B. 1999: PET with [11C]-Metomidate for the Visualization of Adrenocortical Tumors and Discrimination from other Lesions. Clinical Positron Imaging: Official Journal of the Institute for Clinical P.E.T 2(6): 339

Smyczek-Gargya, B.; Fersis, N.; Dittmann, H.; Vogel, U.; Reischl, G.; Machulla, H.-J.; Wallwiener, D.; Bares, R.; Dohmen, B.M. 2004: PET with [18F]fluorothymidine for imaging of primary breast cancer: a pilot study. European Journal of Nuclear Medicine and Molecular Imaging 31(5): 720-724

Belohlávek, O. 2006: PET--options and limitations. Vnitrni Lekarstvi 52(3): 203-204

Liu, Y.; Ghesani, N.; Mirani, N.; Zuckier, L.S. 2006: PET-CT demonstration of extensive muscle metastases from breast cancer. Clinical Nuclear Medicine 31(5): 266-268

Chin, B.B.; Nakamoto, Y.; Kraitchman, D.L.; Marshall, L.; Wahl, R. 2003: PET-CT evaluation of 2-deoxy-2-[18F]fluoro-D-glucose myocardial uptake: effect of respiratory motion. Molecular Imaging and Biology 5(2): 57-64

Zissin, R.; Metser, U.; Lerman, H.; Lievshitz, G.; Safra, T.; Even-Sapir, E. 2006: PET-CT findings in surgically transposed ovaries. British Journal of Radiology 79(938): 110-115

Hall, N.C.; Slone, W.H.; Mayr, N.A.; Yuh, W.T.C.; Wang, J.Z. 2005: PET-CT for tumor delineation: in regard to Heron et al. (Int J Radiat Oncol Biol Phys 2004;60:1419-1424). International Journal of Radiation Oncology Biology Physics 62(4): 1255-6; Author Reply 1256

Kostakoglu, L.; Hardoff, R.; Mirtcheva, R.; Goldsmith, S.J. 2004: PET-CT fusion imaging in differentiating physiologic from pathologic FDG uptake. Radiographics: a Review Publication of the Radiological Society of North America Inc 24(5): 1411-1431

Mattes, D.; Haynor, D.R.; Vesselle, H.; Lewellen, T.K.; Eubank, W. 2003: PET-CT image registration in the chest using free-form deformations. IEEE Transactions on Medical Imaging 22(1): 120-128

Pannu, H.K.; Bristow, R.E.; Cohade, C.; Fishman, E.K.; Wahl, R.L. 2004: PET-CT in recurrent ovarian cancer: initial observations. Radiographics: a Review Publication of the Radiological Society of North America Inc 24(1): 209-223

Skelly, R.T.; McClintock, C.M.; Hughes, S.J.; Irwin, S.T. 2005: PET-CT in the diagnosis of recurrent rectal cancer complicated by left thigh abscess. Ulster Medical Journal 74(2): 105-107

Herzog, P.; Scher, B.; Helmberger, T.; Hahn, K.; Reiser, M.F.; Becker, C.R. 2004: PET-CT interventional tumour therapy. Der Radiologe 44(11): 1088-1095

Metser, U.; Goor, O.; Lerman, H.; Naparstek, E.; Even-Sapir, E. 2004: PET-CT of extranodal lymphoma. Ajr. American Journal of Roentgenology 182(6): 1579-1586

Stelzner, F.; Biersack, H.J.; von Mallek, D.; Reinhardt, M. 2005: PET-CT studies of the support system and continence function of pelvic organs. the pivotal importance of Denonvilliers' fascia for surgical procedures. Der Chirurg; Zeitschrift für Alle Gebiete der Operativen Medizen 76(12): 1168-1174

Jager, P.L.; Slart, R.H.J.A.; Corstens, F.; Oyen, W.J.G.; Hoekstra, O.; Teule, J. 2003: PET-CT: a matter of opinion?. European Journal of Nuclear Medicine and Molecular Imaging 30(3): 470

Cohade, C.; Osman, M.; Marshall, L.N.T.; Wahl, R.N.T.L. 2003: PET-CT: accuracy of PET and CT spatial registration of lung lesions. European Journal of Nuclear Medicine and Molecular Imaging 30(5): 721-726

Richter, J.A..; García-Velloso, M.J..; Pérez-Equiza, C.; Gámez, C.; Pérez-Calvo, J.; Gorosquieta, A.; Crespo, A. 1998: PET-FDG Versus CT in the Staging and Detection of Relapse in Patients with Hodgkin's Disease or Non-Hodgkin Lymphoma. two Years Experience. Clinical Positron Imaging: Official Journal of the Institute for Clinical P.E.T 1(4): 248

Dimitrakopoulou-Strauss, A.; Strauss, L.G.; Rudi, J. 2003: PET-FDG as predictor of therapy response in patients with colorectal carcinoma. Quarterly Journal of Nuclear Medicine: Official Publication of the Italian Association of Nuclear Medicine and the International Association of Radiopharmacology 47(1): 8-13

Richter, J.A..; Torre, W.; García, M.J..; Aramendia, J.M..; Giménez, M.; Brugarolas, A. 1998: PET-FDG in the Preoperative Evaluation of Non Small Cell Lung Cancer (NSCLC) Staging. a Comparison with CT Scanning and MRi. Clinical Positron Imaging: Official Journal of the Institute for Clinical P.E.T 1(4): 247

Villar Luque, L.M.; Sau Llanas, P.; Cantero Sánchez, M.; Maldonado Taillefer, M.; Gómez, A.M. 2005: PET-FDG study in a patient with history of uterine leiomyosarcoma during menstruation and a false positive result. Revista Espanola de Medicina Nuclear 24(3): 205-206

Gulec, S.A.; Daghighian, F.; Essner, R. 2016: PET-Probe: Evaluation of Technical Performance and Clinical Utility of a Handheld High-Energy Gamma Probe in Oncologic Surgery. Annals of Surgical Oncology 23(Suppl 5): 9020-9027

Chiu, K.P.; Wong, C.-H.; Chen, Q.; Ariyaratne, P.; Ooi, H.S.; Wei, C.-L.; Sung, W.-K.K.; Ruan, Y. 2006: PET-Tool: a software suite for comprehensive processing and managing of Paired-End di Tag (PET) sequence data. Bmc Bioinformatics 7: 390

Zanzonico, P. 2006: PET-based biological imaging for radiation therapy treatment planning. Critical Reviews in Eukaryotic Gene Expression 16(1): 61-101

Beer, A.J.; Haubner, R.; Wolf, I.; Goebel, M.; Luderschmidt, S.; Niemeyer, M.; Grosu, A.-L.; Martinez, M.-J.; Wester, H.J.ür.; Weber, W.A.; Schwaiger, M. 2006: PET-based human dosimetry of 18F-galacto-RGD, a new radiotracer for imaging alpha v beta3 expression. Journal of Nuclear Medicine: Official Publication Society of Nuclear Medicine 47(5): 763-769

Jacobs, A.H.; Li, H.; Winkeler, A.; Hilker, R.; Knoess, C.; Rüger, A.; Galldiks, N.; Schaller, B.; Sobesky, J.; Kracht, L.; Monfared, P.; Klein, M.; Vollmar, S.; Bauer, B.; Wagner, R.; Graf, R.; Wienhard, K.; Herholz, K.; Heiss, W.D. 2003: PET-based molecular imaging in neuroscience. European Journal of Nuclear Medicine and Molecular Imaging 30(7): 1051-1065

Doubrovin, M.; Ponomarev, V.; Blasberg, R.G. 2004: PET-based reporter gene imaging. Assessment of endogenous molecular-genetic events. IEEE Engineering in Medicine and Biology Magazine: the Quarterly Magazine of the Engineering in Medicine and Biology Society 23(4): 38-50

Lezmi, Séphane.; Bencsik, A.; Baron, T. 2006: PET-blot analysis contributes to BSE strain recognition in C57Bl/6 mice. Journal of Histochemistry and Cytochemistry: Official Journal of the Histochemistry Society 54(10): 1087-1094

Karlin, L.; Itti, E.; Pautas, C.éc.; Rachid, M.; Bories, D.; Cordonnier, C.; Maury, S.éb. 2006: PET-imaging as a useful tool for early detection of the relapse site in the management of primary myeloid sarcoma. Haematologica 91(12 Suppl): Ecr54

Schindler, T.H.; Facta, A.D.; Prior, J.O.; Campisi, R.; Inubushi, M.; Kreissl, M.C.; Zhang, X.-L.; Sayre, J.; Dahlbom, M.; Schelbert, H.R. 2006: PET-measured heterogeneity in longitudinal myocardial blood flow in response to sympathetic and pharmacologic stress as a non-invasive probe of epicardial vasomotor dysfunction. European Journal of Nuclear Medicine and Molecular Imaging 33(10): 1140-1149

Strobel, K.; Bode, B.; Lardinois, D.; Exner, U. 2007: PET-positive fibrous dysplasia--a potentially misleading incidental finding in a patient with intimal sarcoma of the pulmonary artery. Skeletal Radiology 36(Suppl 1): S24-S28

Lonneux, M. 2005: PET-scan in colorectal cancer. Acta Chirurgica Belgica 105(4): 333-337

Alexánderson, E.; Romero Ibarra, J.é L.; Ricalde, A.; Meave, A. 2005: PET/CT 16-multislice: an anatomo functional view of the heart. Archivos de Cardiologia de Mexico 75(1): 86-89

Martínez, M.-J.; Bercier, Y.; Schwaiger, M.; Ziegler, S.I. 2006: PET/CT Biograph Sensation 16. Performance improvement using faster electronics. NUKLEARMEDIZIN. Nuclear Medicine 45(3): 126-133

Katzel, J.A.; Heiba, S.I. 2005: PET/CT F-18 FDG scan accurately identifies osteoporotic fractures in a patient with known metastatic colorectal cancer. Clinical Nuclear Medicine 30(10): 651-654

Mulligan, M.E.; Badros, A.Z. 2007: PET/CT and MR imaging in myeloma. Skeletal Radiology 36(1): 5-16

Messa, C.; Di Muzio, N.; Picchio, M.; Gilardi, M.C.; Bettinardi, V.; Fazio, F. 2006: PET/CT and radiotherapy. Quarterly Journal of Nuclear Medicine and Molecular Imaging: Official Publication of the Italian Association of Nuclear Medicine and the International Association of Radiopharmacology and Section of the Society Of. 50(1): 4-14

Lucignani, G. 2006: PET/CT cardiology: an area whose boundaries are still out of sight. European Journal of Nuclear Medicine and Molecular Imaging 33(5): 621-623

Roarke, M.C.; Nguyen, B.D. 2007: PET/CT characterization and monitoring of disease activity in lymphomatoid granulomatosis. Clinical Nuclear Medicine 32(3): 258-259

Goodin, G.S.; Shulkin, B.L.; Kaufman, R.A.; McCarville, M.B. 2006: PET/CT characterization of fibroosseous defects in children: 18F-FDG uptake can mimic metastatic disease. AJR. American Journal of Roentgenology 187(4): 1124-1128

Israel, O.; Yefremov, N.; Bar-Shalom, R.; Kagana, O.; Frenkel, A.; Keidar, Z.; Fischer, D. 2005: PET/CT detection of unexpected gastrointestinal foci of 18F-FDG uptake: incidence, localization patterns, and clinical significance. Journal of Nuclear Medicine: Official Publication Society of Nuclear Medicine 46(5): 758-762

Goshen, E.; Davidson, T.; Aderka, D.; Zwas, S.T. 2006: PET/CT detects abdominal wall and port site metastases of colorectal carcinoma. British Journal of Radiology 79(943): 572-577

Iagaru, A.; Henderson, R. 2006: PET/CT follow-up in nonossifying fibroma. AJR. American Journal of Roentgenology 187(3): 830-832

Ben-Haim, S.; Israel, O. 2006: PET/CT for atherosclerotic plaque imaging. Quarterly Journal of Nuclear Medicine and Molecular Imaging: Official Publication of the Italian Association of Nuclear Medicine and the International Association of Radiopharmacology and Section of the Society Of. 50(1): 53-60

Stollfuss, J.; Wieder, H.; Rummeny, E.; Schwaiger, M. 2004: PET/CT for colorectal and hepatic tumors. Der Radiologe 44(11): 1068-1078

Anonymous 2002: PET/CT fusion: what is its role in patient management?. Technology in Cancer Research and Treatment 1(3): 217-218

Sureshbabu, W.; Mawlawi, O. 2005: PET/CT imaging artifacts. Journal of Nuclear Medicine Technology 33(3): 156-161; Quiz: 163-164

Satoh, H.; Ohtsuka, M. 2007: PET/CT imaging in response evaluation of SCLC patients. Lung Cancer 55(1): 123-124

Fischer, B.M.; Mortensen, J.; Langer, S.W.; Loft, A.; Berthelsen, A.K.; Daugaard, G.; Lassen, U.; Hansen, H.H. 2006: PET/CT imaging in response evaluation of patients with small cell lung cancer. Lung Cancer 54(1): 41-49

Nguyen, B.D.; Fletcher, G.P.; Patel, A.C. 2005: PET/CT imaging of conus medullaris metastasis from lung cancer. Clinical Nuclear Medicine 30(4): 253-256

Bruzzi, J.F.; Munden, R.F. 2006: PET/CT imaging of lung cancer. Journal of Thoracic Imaging 21(2): 123-136

Nguyen, B.D.; Ram, P.C.; Roarke, M.C. 2005: PET/CT imaging of metastatic deposit in vertebral Paget's disease. Clinical Nuclear Medicine 30(5): 359-360

Mawlawi, O.; Pan, T.; Macapinlac, H.A. 2006: PET/CT imaging techniques, considerations, and artifacts. Journal of Thoracic Imaging 21(2): 99-110

Le Meunier, L.; Maass-Moreno, R.; Carrasquillo, J.A.; Dieckmann, W.; Bacharach, S.L. 2006: PET/CT imaging: effect of respiratory motion on apparent myocardial uptake. Journal of Nuclear Cardiology: Official Publication of the American Society of Nuclear Cardiology 13(6): 821-830

Deepak, V.; Karanth, P. 2018: Aridification driven diversification of fan-throated lizards from the Indian subcontinent. Molecular Phylogenetics and Evolution 120: 53-62

Czernin, J.; Schelbert, H.R. 2007: PET/CT in cancer patient management. Introduction. Journal of Nuclear Medicine: Official Publication Society of Nuclear Medicine 48 Suppl. 1: 2s-3s

Messa, C.; Bettinardi, V.; Picchio, M.; Pelosi, E.; Landoni, C.; Gianolli, L.; Gilardi, M.C.; Fazio, F. 2004: PET/CT in diagnostic oncology. Quarterly Journal of Nuclear Medicine and Molecular Imaging: Official Publication of the Italian Association of Nuclear Medicine and the International Association of Radiopharmacology and Section of the Society Of. 48(2): 66-75

Højgaard, L.; Specht, L. 2007: PET/CT in head and neck cancer. European Journal of Nuclear Medicine and Molecular Imaging 34(9): 1329-1333

Steinert, H.C. 2004: PET/CT in lymphoma patients. Der Radiologe 44(11): 1060-1067

Devaraj, A.; Cook, G.J.R.; Hansell, D.M. 2007: PET/CT in non-small cell lung cancer staging-promises and problems. Clinical Radiology 62(2): 97-108

Larson, S.M.; Nehmeh, S.A.; Erdi, Y.E.; Humm, J.L. 2005: PET/CT in non-small-cell lung cancer: value of respiratory-gated PET. Chang Gung Medical Journal 28(5): 306-314

Wechalekar, K.; Sharma, B.; Cook, G. 2005: PET/CT in oncology--a major advance. Clinical Radiology 60(11): 1143-1155

Ell, P.J. 2005: PET/CT in oncology: a major technology for cancer care. Chang Gung Medical Journal 28(5): 274-283

Roca, I.; Simó, M.; Sábado, C.; de Toledo, J.S. 2007: PET/CT in paediatrics: it is time to increase its use!. European Journal of Nuclear Medicine and Molecular Imaging 34(5): 628-629

Talbot, J.-N.ël.; Gutman, F.; Fartoux, L.; Grange, J.-D.; Ganne, N.; Kerrou, K.; Grahek, D.; Montravers, F.ço.; Poupon, R.; Rosmorduc, O. 2006: PET/CT in patients with hepatocellular carcinoma using [(18)F]fluorocholine: preliminary comparison with [(18)F]FDG PET/CT. European Journal of Nuclear Medicine and Molecular Imaging 33(11): 1285-1289

Weckesser, M.; Könemann, S.; Brinkmann, M.; Willich, N.; Schober, O. 2004: PET/CT in radiotherapy. Der Radiologe 44(11): 1096-1104

McCarville, M.B.; Christie, R.; Daw, N.C.; Spunt, S.L.; Kaste, S.C. 2005: PET/CT in the evaluation of childhood sarcomas. AJR. American Journal of Roentgenology 184(4): 1293-1304

Goshen, E.; Davidson, T.; Yahalom, R.; Talmi, Y.P.; Zwas, S.T. 2006: PET/CT in the evaluation of patients with squamous cell cancer of the head and neck. International Journal of Oral and Maxillofacial Surgery 35(4): 332-336

Stahl, A.; Wieder, H.; Wester, H.J.; Piert, M.; Lordick, F.; Ott, K.; Rummeny, E.; Schwaiger, M.; Weber, W.A. 2004: PET/CT molecular imaging in abdominal oncology. Abdominal Imaging 29(3): 388-397

Branstetter, B.F.; Meltzer, C.Cidis. 2004: PET/CT of Teflon granulomas. Ajr. American Journal of Roentgenology 183(4): 1173; Author Reply 1173-4

Strobel, K.; Hany, T.F.; Exner, G.U. 2006: PET/CT of a brodie abscess. Clinical Nuclear Medicine 31(4): 210

Goerres, G.W.; Burger, C.; Schwitter, M.R.; Heidelberg, T.-N.H.; Seifert, B.; von Schulthess, G.K. 2003: PET/CT of the abdomen: optimizing the patient breathing pattern. European Radiology 13(4): 734-739

Alessio, A.M.; Kinahan, P.E.; Cheng, P.M.; Vesselle, H.; Karp, J.S. 2004: PET/CT scanner instrumentation, challenges, and solutions. Radiologic Clinics of North America 42(6): 1017-1032 Vii

Nguyen, B.D.; Ram, P.C. 2007: PET/CT staging and posttherapeutic monitoring of anaplastic thyroid carcinoma. Clinical Nuclear Medicine 32(2): 145-149

Tsukamoto, E.; Ochi, S. 2006: PET/CT today: system and its impact on cancer diagnosis. Annals of Nuclear Medicine 20(4): 255-267

Martínez-Villaseñor, D.; Gerson-Cwilich, R. 2006: PET/CT tomography. Usefulness in oncology. Cirugia y Cirujanos 74(4): 295-304

Brink, J.A. 2005: PET/CT unplugged: the merging technologies of PET and CT imaging. AJR. American Journal of Roentgenology 184(5 Suppl): S135-S137

Keidar, Z.; Engel, A.; Nitecki, S.; Bar Shalom, R.; Hoffman, A.; Israel, O. 2003: PET/CT using 2-deoxy-2-[18F]fluoro-D-glucose for the evaluation of suspected infected vascular graft. Molecular Imaging and Biology 5(1): 23-25

Franzius, C.; Juergens, K.U.; Vormoor, J. 2006: PET/CT with diagnostic CT in the evaluation of childhood sarcoma. Ajr. American Journal of Roentgenology 186(2): 581; Author Reply 581-2

Berthelsen, A.K.; Holm, S.; Loft, A.; Klausen, T.L.; Andersen, F.; Højgaard, L. 2005: PET/CT with intravenous contrast can be used for PET attenuation correction in cancer patients. European Journal of Nuclear Medicine and Molecular Imaging 32(10): 1167-1175

Clarke, J.C. 2004: PET/CT "Cometh the hour, cometh the machine?". Clinical Radiology 59(9): 775-776

Mitjavila Casanovas, M. 2006: PET/CT: The point of view from nuclear medicine. Radiologia 48(3): 179-80; author reply 180-1

Schöder, H.; Erdi, Y.E.; Larson, S.M.; Yeung, H.W.D. 2003: PET/CT: a new imaging technology in nuclear medicine. European Journal of Nuclear Medicine and Molecular Imaging 30(10): 1419-1437

Hany, T.F.; von Schulthess, G.K. 2005: PET/CT: combining function and morphology. Ernst Schering Research Foundation Workshop 49: 85-98

Brix, G.; Beyer, T. 2005: PET/CT: dose-escalated image fusion?. Nuklearmedizin. Nuclear Medicine 44(Suppl 1): S51-S57

Seemann, M.D. 2004: PET/CT: fundamental principles. European Journal of Medical Research 9(5): 241-246

Hicks, R.J.; Ware, R.E.; Lau, E.W.F. 2006: PET/CT: will it change the way that we use CT in cancer imaging?. Cancer Imaging: the Official Publication of the International Cancer Imaging Society 6: S52-S62

Sörensen, J.; Johansson, S. 2006: PET/DT can cause clinicians extra concern . A case report illustrates the dilemma of judging additional findings. Lakartidningen 103(42): 3168-3170

El-Haddad, G.; Kumar, R.; Pamplona, R.; Alavi, A. 2006: PET/MRi depicts the exact location of meniscal tear associated with synovitis. European Journal of Nuclear Medicine and Molecular Imaging 33(4): 507-508

Alavi, A.; Lakhani, P.; Mavi, A.; Kung, J.W.; Zhuang, H. 2004: PET: a revolution in medical imaging. Radiologic Clinics of North America 42(6): 983

Maldonado, A. 2002: PET: molecular image. Anales del Sistema Sanitario de Navarra 25(1): 7-9

Scheiner, J.D. 2003: PET: oncological applications. Medicine and Health Rhode Island 86(5): 132-135

Quint, L.E. 2006: PET: other thoracic malignancies. Cancer Imaging: the Official Publication of the International Cancer Imaging Society 6: S82-S88

Beyer, T. 2007: PET: speed dating CT or MRI?. Journal of Nuclear Medicine: Official Publication Society of Nuclear Medicine 48(3): 331

Divgi, C.; Pandit-Taskar, N. 2005: PET: too much of a good thing? Does the plethora of choices impact on patient management?. European Journal of Nuclear Medicine and Molecular Imaging 32(4): 398

Hanafusa, K. 2006: PET?: comfortable whole body checkup. Nihon Hoshasen Gijutsu Gakkai Zasshi 62(6): 781-785

Ring, R.; Bloom, S. 2005: PETA continues to claw at Columbia scientists. Journal of Clinical Investigation 115(5): 1108

Anonymous 1959: PETER Bent Brigham Hospital. Medical Times 87(2): 286-292

Campbell, M. 1951: Morbus coeruleus and its surgical treatment. Lancet 2(6685): 647-653

Essex-Lopresti, P. 1951: PETER Gordon Lawrence Essex-Lopresti F.R.C.S.E., D.A. Lancet 1(6670): 1372

Buck, P.H. 1951: PETER Henry Buck. Lancet 2(6693): 1094

Macleod, P.J. 1951: PETER John Macleod. Lancet 1(6653): 534-535

Anonymous 1951: PETER Pan Club, a day nursery in Kensington. Nursing Times 47(20): 491-494

Anonymous 1950: PETERBOROUGH'S all-new civic hospital. Canadian Hospital 27(9): 38-41

Anonymous 1952: PETHIDINE and the liver. Medical World 77(13): 340-341

Anonymous 1959: PETROLEUM distillates (furniture polish), aspirin, and other ingestions and suicidal attempts. New York State Journal of Medicine 59(13): 2597-2601

Anonymous 2003: PET_Mail: a low-key, high-tech PET community. Journal of Nuclear Medicine: Official Publication Society of Nuclear Medicine 44(7): 32n

Kiel, J.A.K.W.; Veenhuis, M.; van der Klei, I.J. 2006: PEX genes in fungal genomes: common, rare or redundant. Traffic 7(10): 1291-1303

Kim, S.-K.; Cargioli, T.G.; Machluf, M.; Yang, W.; Sun, Y.; Al-Hashem, R.; Kim, S.U.; Black, P.M.; Carroll, R.S. 2005: PEX-producing human neural stem cells inhibit tumor growth in a mouse glioma model. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 11(16): 5965-5970

Michelakakis, H.M.; Zafeiriou, D.I.; Moraitou, M.S.; Gootjes, J.; Wanders, R.J.A. 2004: PEX1 deficiency presenting as Leber congenital amaurosis. Pediatric Neurology 31(2): 146-149

Lasagni, L.; Grepin, R.; Mazzinghi, B.; Lazzeri, E.; Meini, C.; Sagrinati, C.; Liotta, F.; Frosali, F.; Ronconi, E.; Alain-Courtois, N.; Ballerini, L.; Netti, G.Stefano.; Maggi, E.; Annunziato, F.; Serio, M.; Romagnani, S.; Bikfalvi, A.; Romagnani, P. 2007: PF-4/CXCL4 and CXCL4L1 exhibit distinct subcellular localization and a differentially regulated mechanism of secretion. Blood 109(10): 4127-4134

Warkentin, T.E. 2007: PF4-dependent immunoassays and inferential detection of HIT antibodies. Journal of Thrombosis and Haemostasis: Jth 5(2): 232-234

Hézard, N.; Metz, D.; Nazeyrollas, P.; Droullé, C.; Potron, G.ér.; Nguyen, P. 2002: PFA-100 and flow cytometry: can they challenge aggregometry to assess antiplatelet agents, other than GPIIbIIIa blockers, in coronary angioplasty?. Thrombosis Research 108(1): 43-47

McGlennan, A.; Esler, M.; Stocks, G.; Pandit, V. 2004: PFA-100 and regional analgesia in a parturient after ibuprofen overdose. British Journal of Anaesthesia 92(5): 776-777

Mandal, N.G. 2004: PFA-100(R) and regional analgesia. British Journal of Anaesthesia 93(3): 468; Author Reply 468-9

Ataş, Bülent.; Caksen, Hüseyin.; Arslan, Sükrü.; Tuncer, Oğuz.; Kirimi, E.; Odabaş, D. 2003: PFAPA syndrome mimicking familial Mediterranean fever: report of a Turkish child. Journal of Emergency Medicine 25(4): 383-385

Kurtaran, H.; Karadağ, A.; Catal, F.; Aktaş, D. 2004: PFAPA syndrome: a rare cause of periodic fever. Turkish Journal of Pediatrics 46(4): 354-356

Hernández-Bou, S.; Giner, M.; Plaza, A.M.; Sierra, J.I.; Martín Mateos, M.A. 2003: PFAPA syndrome: with regard to a case. Allergologia et Immunopathologia 31(4): 236-239

Hindmarsh, J.P.; Su, J.; Flanagan, J.; Singh, H. 2005: PFG-NMR analysis of intercompartment exchange and inner droplet size distribution of W/O/W emulsions. Langmuir 21(20): 9076-9084

Fischbach, I.; Thieme, K.; Hoffmann, A.; Hehn, M.; Schnell, I. 2003: PFG-assisted selection and suppression of 1H NMR signals in the solid state under fast MAS. Journal of Magnetic Resonance 165(1): 102-115

Mimura, K. 2005: PFGE analysis of Mycobacterium kansasii isolates in Okayama Prefecture. Kekkaku: 80(2): 63-68

Grammenou, P.; Spiliopoulou, I.; Sazakli, E.; Papapetropoulou, M. 2006: PFGE analysis of enterococci isolates from recreational and drinking water in Greece. Journal of Water and Health 4(2): 263-269

Käppeli, S. 2004: PFLEGE periodical as a mirror of science. Pflege 17(3): 140-144

Scollard, M. 2007: PFM crowns. Journal of the American Dental Association 138(2): 152; Author Reply 152-54

Kaplan, A.V.; Lukovits, T.G.; Robb, J.F. 2007: PFO closure for prevention of recurrent stroke in patients after cryptogenic stroke: the imperative of completing randomized controlled trials. Catheterization and Cardiovascular Interventions: Official Journal of the Society for Cardiac Angiography and Interventions 69(1): 6-8

Meier, B. 2005: PFO closure, when the going gets tough .. Catheterization and Cardiovascular Interventions: Official Journal of the Society for Cardiac Angiography and Interventions 64(3): 345-347

Messé, S.R.; Cucchiara, B.; Luciano, J.; Kasner, S.E. 2005: PFO management: neurologists vs cardiologists. Neurology 65(1): 172-173

Britt, J.D. 2003: PFS and outpatient therapy: managing minutes and edits as a team. Patient Accounts 26(4): 2-3

Hyderi, A. 2006: PG thesis: idealistic vs realistic. Indian Journal of Pediatrics 73(4): 373-374

Andersen, G.; Wegner, L.; Jensen, D.P.; Glümer, C.; Tarnow, L.; Drivsholm, T.; Poulsen, P.; Hansen, S.K.; Nielsen, E.-M.D.; Ek, J.; Mouritzen, P.; Vaag, A.; Parving, H.-H.; Borch-Johnsen, K.; Jørgensen, T.; Hansen, T.; Pedersen, O. 2005: PGC-1alpha Gly482Ser polymorphism associates with hypertension among Danish whites. Hypertension 45(4): 565-570

Mortensen, O.H.; Frandsen, L.; Schjerling, P.; Nishimura, E.; Grunnet, N. 2006: PGC-1alpha and PGC-1beta have both similar and distinct effects on myofiber switching toward an oxidative phenotype. American Journal of Physiology. Endocrinology and Metabolism 291(4): E807-E816

Wende, A.R.; Huss, J.M.; Schaeffer, P.J.; Giguère, V.; Kelly, D.P. 2005: PGC-1alpha coactivates PDK4 gene expression via the orphan nuclear receptor ERRalpha: a mechanism for transcriptional control of muscle glucose metabolism. Molecular and Cellular Biology 25(24): 10684-10694

Shlomai, A.; Paran, N.; Shaul, Y. 2006: PGC-1alpha controls hepatitis B virus through nutritional signals. Proceedings of the National Academy of Sciences of the United States of America 103(43): 16003-16008

Leone, T.C.; Lehman, J.J.; Finck, B.N.; Schaeffer, P.J.; Wende, A.R.; Boudina, S.; Courtois, M.; Wozniak, D.F.; Sambandam, N.; Bernal-Mizrachi, C.; Chen, Z.; Holloszy, J.O.; Medeiros, D.M.; Schmidt, R.E.; Saffitz, J.E.; Abel, E.D.; Semenkovich, C.F.; Kelly, D.P. 2005: PGC-1alpha deficiency causes multi-system energy metabolic derangements: muscle dysfunction, abnormal weight control and hepatic steatosis. Plos Biology 3(4): E101

Franks, P.W.; Loos, R.J.F. 2006: PGC-1alpha gene and physical activity in type 2 diabetes mellitus. Exercise and Sport Sciences Reviews 34(4): 171-175

Southgate, R.J.; Bruce, C.R.; Carey, A.L.; Steinberg, G.R.; Walder, K.; Monks, R.; Watt, M.J.; Hawley, J.A.; Birnbaum, M.J.; Febbraio, M.A. 2005: PGC-1alpha gene expression is down-regulated by Akt- mediated phosphorylation and nuclear exclusion of FoxO1 in insulin-stimulated skeletal muscle. Faseb Journal: Official Publication of the Federation of American Societies for Experimental Biology 19(14): 2072-2074

Franks, P.W.; Barroso, Iês.; Luan, J'an.; Ekelund, U.; Crowley, V.E.F.; Brage, Søren.; Sandhu, M.S.; Jakes, R.W.; Middelberg, R.P.S.; Harding, A-Helen.; Schafer, A.J.; O'Rahilly, S.; Wareham, N.J. 2003: PGC-1alpha genotype modifies the association of volitional energy expenditure with [OV0312]O2max. Medicine and Science in Sports and Exercise 35(12): 1998-2004

Nervina, J.M.; Magyar, C.E.; Pirih, F.Q.; Tetradis, S. 2006: PGC-1alpha is induced by parathyroid hormone and coactivates Nurr1-mediated promoter activity in osteoblasts. Bone 39(5): 1018-1025

Norrbom, J.; Sundberg, C.J.; Ameln, H.; Kraus, W.E.; Jansson, E.; Gustafsson, T. 2004: PGC-1alpha mRNA expression is influenced by metabolic perturbation in exercising human skeletal muscle. Journal of Applied Physiology 96(1): 189-194

Rasbach, K.A.; Schnellmann, R.G. 2007: PGC-1alpha over-expression promotes recovery from mitochondrial dysfunction and cell injury. Biochemical and Biophysical Research Communications 355(3): 734-739

Sandri, M.; Lin, J.; Handschin, C.; Yang, W.; Arany, Z.P.; Lecker, S.H.; Goldberg, A.L.; Spiegelman, B.M. 2006: PGC-1alpha protects skeletal muscle from atrophy by suppressing FoxO3 action and atrophy-specific gene transcription. Proceedings of the National Academy of Sciences of the United States of America 103(44): 16260-16265

Thijssen-Timmer, D.C.; Schiphorst, M.P.-T.; Kwakkel, J.; Emter, R.; Kralli, A.; Wiersinga, W.M.; Bakker, O. 2006: PGC-1alpha regulates the isoform mRNA ratio of the alternatively spliced thyroid hormone receptor alpha transcript. Journal of Molecular Endocrinology 37(2): 251-257

Valle, I.; Alvarez-Barrientos, A.; Arza, E.; Lamas, S.; Monsalve, M.ía. 2005: PGC-1alpha regulates the mitochondrial antioxidant defense system in vascular endothelial cells. Cardiovascular Research 66(3): 562-573

McGill, J.K.; Beal, M.Flint. 2006: PGC-1alpha, a new therapeutic target in Huntington's disease?. Cell 127(3): 465-468

Tiraby, C.; Langin, D. 2005: PGC-1alpha, a transcriptional coactivator involved in metabolism. Medecine Sciences: M/S 21(1): 49-54

Srivastava, S.; Barrett, J.N.; Moraes, C.T. 2007: PGC-1alpha/beta upregulation is associated with improved oxidative phosphorylation in cells harboring nonsense mtDNA mutations. Human Molecular Genetics 16(8): 993-1005

Liang, H.; Ward, W.F. 2006: PGC-1alpha: a key regulator of energy metabolism. Advances in Physiology Education 30(4): 145-151

Soyal, S.; Krempler, F.; Oberkofler, H.; Patsch, W. 2006: PGC-1alpha: a potent transcriptional cofactor involved in the pathogenesis of type 2 diabetes. Diabetologia 49(7): 1477-1488

Li, D. 2005: PGC-1alpha: looking behind the sweet treat for porphyria. Cell 122(4): 487-489

Rodríguez-Calvo, R.; Jové, M.; Coll, T.; Camins, A.; Sánchez, R.M.; Alegret, M.; Merlos, M.; Pallàs, M.è; Laguna, J.C.; Vázquez-Carrera, M. 2006: PGC-1beta down-regulation is associated with reduced ERRalpha activity and MCAD expression in skeletal muscle of senescence-accelerated mice. Journals of Gerontology. Series a Biological Sciences and Medical Sciences 61(8): 773-780

Schuler, M.; Ali, F.; Chambon, Céline.; Duteil, D.; Bornert, J-Marc.; Tardivel, A.; Desvergne, Béatrice.; Wahli, W.; Chambon, P.; Metzger, D. 2006: PGC1alpha expression is controlled in skeletal muscles by PPARbeta, whose ablation results in fiber-type switching, obesity, and type 2 diabetes. Cell Metabolism 4(5): 407-414

Colls, P.; Sandalinas, M.; Pagidas, K.; Munné, S. 2004: PGD analysis for aneuploidy in a patient heterozygous for a polymorphism of chromosome 16 (16qh-). Prenatal Diagnosis 24(9): 741-744

Donoso, P.; Devroey, P. 2007: PGD for aneuploidy screening: an expensive hoax?. Best Practice and Research. Clinical Obstetrics and Gynaecology 21(1): 157-168

Delhanty, J.D.A. 2004: PGD for reciprocal translocations. Prenatal Diagnosis 24(7): 552

Kalfoglou, A.L.; Scott, J.; Hudson, K. 2005: PGD patients' and providers' attitudes to the use and regulation of preimplantation genetic diagnosis. Reproductive Biomedicine Online 11(4): 486-496

Uehara, Y. 2004: PGD(2)/L-PGDS system in hypertension and renal injury. Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica 123(1): 23-33

Mastenbroek, S.; Twisk, M.; Goddijn, M.; van der Veen, F.; Repping, S.; Bossuyt, P.M.M.; Korevaar, J.C.; Twisk, M.; Heineman, M.Jan. 2006: PGD--a model to evaluate efficacy?. Fertility and sterility 85(2): 534-5; author reply 535-6

Churn, L. 2003: PGDs provide clinical benefits without compromise. Nursing Times 99(33): 31

Clément, N.; Glorian, M.; Raymondjean, M.; Andréani, M.; Limon, I. 2006: PGE2 amplifies the effects of IL-1beta on vascular smooth muscle cell de-differentiation: a consequence of the versatility of PGE2 receptors 3 due to the emerging expression of adenylyl cyclase 8. Journal of Cellular Physiology 208(3): 495-505

Yogev, Y.; Ben-Haroush, A.; Horowitz, E.R.; Chen, R.; Hod, M.; Kaplan, B. 2003: PGE2 induction of labor for consistent decreased perception of fetal movements at term. International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics 82(2): 173-178

Anonymous 2005: PGE2 produced by lung cancer suppresses immune function through T-regulatory cells and can be blocked by the COX2 inhibitor Celebrex. Cancer Biology and Therapy 4(8): V-Vi

Kessen, U.A.; Schaloske, R.H.; Stephens, D.L.; Killermann Lucas, K.; Dennis, E.A. 2005: PGE2 release is independent of upregulation of Group V phospholipase A2 during long-term stimulation of P388D1 cells with LPS. Journal of Lipid Research 46(11): 2488-2496

Jeffries, D. 2005: PGEA is dead, long live PGE!. British Journal of General Practice: the Journal of the Royal College of General Practitioners 55(511): 160

Morcelli, C.P.R.; Figueiredo, A.M.G.; Sarkis, J.E.S.; Enzweiler, J.; Kakazu, M.; Sigolo, J.B. 2005: PGEs and other traffic-related elements in roadside soils from São Paulo, Brazil. Science of the Total Environment 345(1-3): 81-91

Marchetti, L.; Sabbieti, M.G.; Agas, D.; Menghi, M.; Materazzi, G.; Menghi, G.; Hurley, M.M. 2006: PGF2alpha increases FGF-2 and FGFR2 trafficking in Py1a rat osteoblasts via clathrin independent and importin beta dependent pathway. Journal of Cellular Biochemistry 97(6): 1379-1392

Thuresson, E.D.; Lakkides, K.M.; Smith, W.L. 2002: PGG2, 11R-HPETE and 15R/S-HPETE are formed from different conformers of arachidonic acid in the prostaglandin endoperoxide H synthase-1 cyclooxygenase site. Advances in Experimental Medicine and Biology 507: 67-72

Boutaud, O.; Montine, T.J.; Chang, L.; Klein, W.L.; Oates, J.A. 2006: PGH2-derived levuglandin adducts increase the neurotoxicity of amyloid beta1-42. Journal of Neurochemistry 96(4): 917-923

Song, H.-y.; Yang, Q.-e.; Yu, C.-y. 2002: PGM1 genotyping by PCR-SSCP. Fa Yi Xue Za Zhi 18(3): 152-154

Jiang, C.A.; Leong, T.-Y.; Poh, K.-L. 2005: PGMC: a framework for probabilistic graphic model combination. AMIA . Annual Symposium Proceedings. AMIA Symposium 2005: 370-374

Li, J.; Busch, L.C.; Kuhnel, W. 2000: PGP 9.5 immunohistochemical study on the development of the enteric nervous system of trisomy 16 mouse embryos and their normal littermates. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. Acta Academiae Medicinae Sinicae 22(2): 159-164

Yamashita, K.; Park, H.L.; Kim, M.S.; Osada, M.; Tokumaru, Y.; Inoue, H.; Mori, M.; Sidransky, D. 2006: PGP9.5 methylation in diffuse-type gastric cancer. Cancer Research 66(7): 3921-3927

Abbas, Z.; Jafri, W.; Shah, S.H.A.; Khokhar, N.; Zuberi, S.J. 2004: PGS consensus statement on management of hepatitis B virus infection--2003. Jpma. Journal of the Pakistan Medical Association 54(3): 150-158

Zuccaccia, D.; Sabatini, S.; Bellachioma, G.; Cardaci, G.; Clot, E.; Macchioni, A. 2003: PGSE and NOE NMR evidence for higher order aggregation in some cationic ruthenium complexes in both protic and aprotic solvents. Inorganic Chemistry 42(18): 5465-5467

Anil Kumar, P.G.; Pregosin, P.S.; Schmid, T.M.; Consiglio, G. 2004: PGSE diffusion, 1H-19F HOESY and NMR studies on several [Rh(1,5-COD)(Biphemp)]X complexes: detecting positional anion effects. Magnetic Resonance in Chemistry: Mrc 42(9): 795-800

Mccord, H. 1961: PGSR testing of the blind. Journal of Rehabilitation 27: 24

Castro, C.M.; Grois, J.; Salgado, A.L.; De Soldati, L. 1962: PH 203 in the treatment of acute thrombophlebitis. El Dia Medico 34: 1879-1882

Khutoryanskiy, V.V.; Dubolazov, A.V.; Nurkeeva, Z.S.; Mun, G.A. 2004: PH effects in the complex formation and blending of poly(acrylic acid) with poly(ethylene oxide). Langmuir 20(9): 3785-3790

Maison, R.; Kurla, D. 1954: PH indicator applicable in diagnosis. La Semana Medica 104(14): 410-412

Boulanger, P. 1955: Fractionation chromatography in biological chemistry, technics of analysis and practical applications. Produits Pharmaceutiques 10(12): 761-768

Kaczmarek, U. 2004: PH values and fluoride levels in some tea brands. Annales Academiae Medicae Stetinensis 50(Suppl 1): 58-61

Zheng, Z.-H.; Wang, G.-Z. 2004: PH-spline approximation for Bézier curve and rendering offset. Journal of Zhejiang University. Science 5(3): 343-349

Rosenberg, M.M.; Tanaka, T.; Adler, H.E. 1950: Toxicity of chlordan to laying pullets. American Journal of Veterinary Research 11(39): 236-239

Delk, M.; Bornstein, W.; Morley, A. 2004: PHA co-produces instructional videotape titled "Discussing Unanticipated Outcomes and Disclosing Medical Errors". Gha Today 48(6): 6-7

Parker, J.A. 2004: The truth about the Scruggs lawsuits. Gha Today 48(7): 11

Soncini, C.; Carpinelli, P.; Gianellini, L.; Fancelli, D.; Vianello, P.; Rusconi, L.; Storici, P.; Zugnoni, P.; Pesenti, E.; Croci, V.; Ceruti, R.; Giorgini, M.L.; Cappella, P.; Ballinari, D.; Sola, F.; Varasi, M.; Bravo, R.; Moll, J.ür. 2006: PHA-680632, a novel Aurora kinase inhibitor with potent antitumoral activity. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 12(13): 4080-4089

Angly, F.; Rodriguez-Brito, B.; Bangor, D.; McNairnie, P.; Breitbart, M.; Salamon, P.; Felts, B.; Nulton, J.; Mahaffy, J.; Rohwer, F. 2005: PHACCS, an online tool for estimating the structure and diversity of uncultured viral communities using metagenomic information. BMC bioinformatics 6: 41

Fryssira, H.; Tsitsika, A.; Lourida, A.; Manolaki, N. 2006: PHACE syndrome: a new case. Clinical Pediatrics 45(1): 89-92

Lasky, J.B.; Sandu, M.; Balashanmugan, A. 2004: PHACE syndrome: association with persistent fetal vasculature and coloboma-like iris defect. Journal of AAPOS: the official publication of the American Association for Pediatric Ophthalmology and Strabismus 8(5): 495-498

Cannady, S.B.; Kahn, T.A.; Traboulsi, E.I.; Koltai, P.J. 2006: PHACE syndrome: report of a case with a glioma of the anterior skull base and ocular malformations. International Journal of Pediatric Otorhinolaryngology 70(3): 561-564

Lin, M-Chih.; Chen, C-Huei.; Chi, C-Shiang. 2003: PHACE syndrome: report of one case. Acta Paediatrica Taiwanica 44(6): 379-382

Ruiz-de-Luzuriaga, A.M.; Bardo, D.; Stein, S.L. 2006: PHACES association. Journal of the American Academy of Dermatology 55(6): 1072-1074

Durusoy, C.; Mihci, E.; Tacoy, S.; Ozaydin, E.; Alpsoy, E. 2006: PHACES syndrome presenting as hemangiomas, sternal clefting and congenital ulcerations on the helices. Journal of Dermatology 33(3): 219-222

Ghosh, A.; Tibrewal, S.R.; Thapa, R. 2007: PHACES syndrome with congenital hypothyroidism. Indian Pediatrics 44(2): 144-147

Torer, B.; Gulcan, H.; Kilicdag, H.; Derbent, M. 2007: PHACES syndrome with small, late-onset hemangiomas. European Journal of Pediatrics 166(12): 1293-1295

Bhattacharya, J.J.; Luo, C.B.; Alvarez, H.; Rodesch, G.; Pongpech, S.; Lasjaunias, P.L. 2004: PHACES syndrome: a review of eight previously unreported cases with late arterial occlusions. Neuroradiology 46(3): 227-233

Wendelin, G.; Kitzmüller, E.; Salzer-Muhar, U. 2004: PHACES: a neurocutaneous syndrome with anomalies of the aorta and supraaortic vessels. Cardiology in the Young 14(2): 206-209

Nomura, M.; Lowry, C.V. 1967: Phage F2 Rna-Directed Binding of Formylmethionyl-Trna to Ribosomes and the Role of 30s Ribosomal Subunits in Initiation of Protein Synthesis. Proceedings of the National Academy of Sciences of the United States of America 58(3): 946-953

Moodie, P.; Metcalfe, S.; Dougherty, S. 2006: PHARMAC and EpiPen for anaphylaxis. New Zealand Medical Journal 119(1236): U2038

Rosevear, M. 2006: PHARMAC and Herceptin for early-stage breast cancer in new Zealand: Herceptin or deception?. New Zealand Medical Journal 119(1235): U2014

Gillies, J.; Brown, J.; Byrnes, C.; Farrell, A.; Graham, D. 2005: PHARMAC and Ventolin in New Zealand. New Zealand Medical Journal 118(1220): U1616

Grocott, R.; Metcalfe, S.; Moodie, P. 2006: PHARMAC and erythropoietin for cancer patients. New Zealand Medical Journal 119(1236): U2039

White, H.; Ellis, C. 2005: PHARMAC and lack of funding for clopidogrel. New Zealand Medical Journal 119(1228): U1808

Silva, A.C.; Souza, A.F. 2018: Aridity drives plant biogeographical sub regions in the Caatinga, the largest tropical dry forest and woodland block in South America. Plos one 13(4): E0196130

Metcalfe, S.; Moodie, P. 2007: PHARMAC and statins--correction is needed. New Zealand Medical Journal 120(1250): U2453

Moodie, P.; Dougherty, S.; Metcalfe, S. 2006: PHARMAC and statins--getting the best population health gains. New Zealand Medical Journal 119(1238): U2092

Ellis, C.; White, H. 2006: PHARMAC and the statin debacle. New Zealand Medical Journal 119(1236): U2033

Holt, S.; Harwood, M.; Aldington, S.; Beasley, R. 2005: PHARMAC and tobacco control in new Zealand: government policy 'up in smoke'. New Zealand Medical Journal 118(1216): U1502

Metcalfe, S.; Moodie, P.; McNee, W. 2005: PHARMAC and tobacco control in New Zealand: two licensed funded options are already available. New Zealand Medical Journal 118(1217): U1544; Author Reply U1544; Discussion U1544

Ellis, P.; Mulder, R.; Porter, R. 2006: PHARMAC and treatment of bipolar depression--the limits of utilitarianism. New Zealand Medical Journal 119(1231): U1924

Metcalfe, S.; Dougherty, S.; Brougham, M.; Moodie, P. 2003: PHARMAC measures savings elsewhere to the health sector. New Zealand Medical Journal 116(1170): U362

Whyte, K. 2005: PHARMAC not funding some treatments for rare, life-threatening diseases: bosentan as an example. New Zealand Medical Journal 118(1226): U1759

Metcalfe, S.; Moodie, P.; Grocott, R.; Wilkinson, T. 2005: PHARMAC responds on TNF inhibitors for inflammatory arthritis. New Zealand Medical Journal 118(1227): U1799

Metcalfe, S.; Wilkinson, T.; Rasiah, D. 2006: PHARMAC responds on agents to prevent osteoporotic fractures. New Zealand Medical Journal 119(1230): U1895

Metcalfe, S.; Dougherty, S. 2005: PHARMAC responds on long-acting inhalers for COPD. New Zealand Medical Journal 118(1225): U1743

Metcalfe, S.; Evans, J.; Moodie, P. 2005: PHARMAC responds on long-acting insulin analogues. New Zealand Medical Journal 118(1224): U1716

Metcalfe, S.; Moodie, P.; Davies, A.; McNee, W.; Dougherty, S. 2005: PHARMAC responds on salbutamol. New Zealand Medical Journal 118(1221): U1644

Moodie, P. 2005: PHARMAC responds on tolterodine for overactive bladder. New Zealand Medical Journal 119(1229): U1871

Metcalfe, S.; Rasiah, D.; Dougherty, S. 2005: PHARMAC responds on treatments for pulmonary arterial hypertension. New Zealand Medical Journal 118(1227): U1805

Metcalfe, S.; Brougham, M.; Moodie, P.; Grocott, R. 2005: PHARMAC responds to Richard Milne on discounting health benefits and costs. New Zealand Medical Journal 118(1219): U1600

Davies, A.; Metcalfe, S.; Moodie, P.; McNee, W. 2005: PHARMAC responds to Stewart Mann on dihydropyridine calcium channel antagonists. New Zealand Medical Journal 118(1220): U1621

Louthan, A.M.; Pringle, R.M.; Goheen, J.R.; Palmer, T.M.; Morris, W.F.; Doak, D.F. 2018: Aridity weakens population-level effects of multiple species interactions on Hibiscus meyeri. Proceedings of the National Academy of Sciences of the United States of America 115(3): 543-548

Grocott, R.; Moodie, P. 2006: PHARMAC seeks clinical feedback on its cost-utility analysis methodology. New Zealand Medical Journal 119(1239): U2113

Moodie, P.; McNee, W.; Metcalfe, S. 2005: PHARMAC welcomes debate. New Zealand Medical Journal 118(1218): U1572

Moodie, P.; Dougherty, S. 2006: PHARMAC's response on clopidogrel. New Zealand Medical Journal 119(1229): U1872

Crausaz, S.; Metcalfe, S. 2005: PHARMAC's response on gemcitabine and transparency. New Zealand Medical Journal 118(1225): U1741

Metcalfe, S.; Crausaz, S.; Moodie, P.; McNee, W. 2005: PHARMAC's response on temozolomide and funding costly medicines that prolong life shortly. New Zealand Medical Journal 118(1227): U1806

Anonymous 1952: PHARMACEUTICAL Benefits Act. Medical Journal of Australia 2(13): 452

Anonymous 1951: PHARMACEUTICAL Benefits Act, 1947-1949. Medical Journal of Australia 2(19): 643-644

Anonymous 1953: PHARMACEUTICAL curriculum. American Journal of Pharmacy and the Sciences Supporting Public Health 125(7): 220-221

Anonymous 1959: PHARMACEUTICAL economics and problems. Gazette Medicale de France 66: 1349-1350

Anonymous 1953: PHARMACEUTICAL fact and fancy. New England Journal of Medicine 248(25): 1075-1076

Anonymous 1952: PHARMACEUTICAL industry and medical men. Journal of the Indian Medical Association 22(3): 129-131

Anonymous 1960: PHARMACEUTICALS in new China. Chinese Medical Journal 80: 208-213

Krugman, S.; Ward, R. 1951: Air sterilization in an infants' ward; effect of triethylene glycol vapor and dust-suppressive measures on respiratory cross infection rate. Journal of the American Medical Association 145(11): 775-780

Hirst, A.E.; Munson, R. 1953: Amyloidosis from regional ileitis with multiple fistulas and abscesses. Medical Arts and Sciences 7(1): 9-12

Morris, J.N.; Heady, J.A. 1955: Social and biological factors in infant mortality. I. Objects and methods. Lancet 268(6859): 343-349

Anonymous 1952: PHARMACOLOGY of isoniazid. Lancet 2(6728): 276-277

Anonymous 1955: PHARMACOLOGY of reserpine. Lancet 268(6863): 548-549

Anonymous 1957: PHARMACOLOGY of salicylate. British Medical Journal 2(5048): 812

Anonymous 1958: PHARMACOPOEIAS and formularies. British Medical Journal 2(5096): 601-602

Anonymous 1951: PHARMACY at Royal Naval Hospital, Halifax, N. S. Canadian Hospital 28(5): 40

Anonymous 1952: PHARMACY centenary. British Medical Journal 2(4797): 1302

Anonymous 1952: PHARMACY schools: classification by private association. Journal of the American Medical Association 149(2): 192

Anonymous 1958: PHARYNGEAL diverticula. Lancet 2(7043): 404-405

Anonymous 1955: PHARYNGOESOPHAGEAL diverticuli; diagnosis and management. Medical Times 83(6): 640-643

Dixon, S.L.; Smondyrev, A.M.; Rao, S.N. 2006: PHASE: a novel approach to pharmacophore modeling and 3D database searching. Chemical Biology and Drug Design 67(5): 370-372

Richards, A.; Barkham, M.; Cahill, J.; Richards, D.; Williams, C.; Heywood, P. 2003: PHASE: a randomised, controlled trial of supervised self-help cognitive behavioural therapy in primary care. British Journal of General Practice: the Journal of the Royal College of General Practitioners 53(495): 764-770

Gardner, P. 2005: PHCC alumnus delivers graduation address. Florida Nurse 53(1): 21-22

Vacanti, F.X. 2004: PHEMA as a fibrous capsule-resistant breast prosthesis. Plastic and Reconstructive Surgery 113(3): 949-952

Hicks, C.R.; Chirila, T.V.; Vijayasekaran, S.; Crawford, G.J. 2006: PHEMA as a keratoprosthesis material. British Journal of Ophthalmology 90(1): 124

Ferruti, P.; Grigolini, M.; Ranucci, E. 2004: PHEMA hydrogels obtained by a novel low-heat curing procedure with a potential for in situ preparation. Macromolecular Bioscience 4(6): 591-600

Phemister, D.B. 1952: PHEMISTER, Dallas Burton. Journal of the American Medical Association 148(3): 216

Anonymous 1957: PHENMETRAZINE hydrochloride. Journal of the American Medical Association 163(5): 357

Anonymous 1952: PHENOMENAL growth in population taxes facilities of the country's dental schools. Journal of the American Dental Association 46(4): 455-457

Anonymous 1956: PHENOTHIAZINE and thyroid function. Nutrition Reviews 14(6): 186-188

Anonymous 1960: PHENOTHIAZINES in psychiatry. Die Medizinische Welt 17: 946-949

Anonymous 1960: PHENOTHIAZINES in psychiatry. II. Die Medizinische Welt 18: 1023-1026

Ostow, M. 1953: Transvestism. Journal of the American Medical Association 152(16): 1553

Anonymous 1953: PHENTOLAMINE methanesulfonate. Journal of the American Medical Association 152(16): 1534-1535

Anonymous 1960: PHENYLACETIC acid and the production of serotonin. Nutrition Reviews 18: 47-48

Anonymous 1953: PHENYLBUTAZONE on trial. British Medical Journal 2(4843): 982-983

Anonymous 1956: PHILADELPHIA General Hospital. Medical Times 84(12): 1386-1393

Pal, S.; Woods, R.P.; Panjiyar, S.; Sowell, E.; Narr, K.L.; Joshi, S.H. 2017: A Riemannian Framework for Linear and Quadratic Discriminant Analysis on the Tangent Space of Shapes. Conference on Computer Vision and Pattern Recognition Workshops. IEEE Computer Society Conference on Computer Vision and Pattern Recognition. Workshops 2017: 726-734

Anonymous 1951: PHILADELPHIA'S Catholic hospitals. Hospital Progress 32(5): 133-136

Gersonde, J.R.; Hamblin, L.W. 1952: Accreditation of nursing schools; a boon or a bane to hospital patients?. Hospitals 26(8): 67-69

Franklin, P. 1951: PHILIP Franklin. Lancet 1(6647): 177

Litvin, P. 1951: PHILIP Litvin, M.D., LL.B. (1907-1951). Medical annals of the District of Columbia 20(10): 579

Ellinger, P. 1952: PHILIPP Ellinger. Lancet 2(6738): 785

Meltzer, J.I. 1957: A brief survey of tuberculosis in USAREUR. Medical Bulletin of the U. S. Army Europe. United States. Army Europe. Medical Division 14(4): 76-81

Anonymous 1953: PHILOSOPHIES and practices in school health. Public Health Reports 68(2): 213-217

Alesen, L.A. 1952: The physician's responsibility as a leader. Northwest Medicine 51(10): 855-859

Kecmanović, D.; Pavlov, M.; Ceranić, M.; Sepetkovski, A.; Kovacevi, P.; Stamenković, A. 2005: PHLEBODIA (diosmine): a role in the management of bleeding nonprolapsed hemorrhoids. Acta Chirurgica Iugoslavica 52(1): 115-116

Kulbok, P.A.; Reed, J. 2006: PHN competencies. Public Health Nursing 23(2): 97-98

Oatway, W.H. 1951: Delays in the diagnosis of tuberculosis from the incautious use of antibiotics. Arizona Medicine 8(7): 25-28

De LORENZO, J.; Jannini, P. 1951: Nitrogen mustard in the treatment of Hodgkin's disease, lymphosarcoma, leukemia and related diseases. Arquivos de Clinica 12(3): 141-161

Merkeev, I.V.; Mironov, A.A. 2006: PHOG-BLAST--a new generation tool for fast similarity search of protein families. Bmc Evolutionary Biology 6: 51

Merkeev, I.V.; Novichkov, P.S.; Mironov, A.A. 2006: PHOG: a database of supergenomes built from proteome complements. Bmc Evolutionary Biology 6: 52

Anonymous 1958: PHOSPHATE activity in white cells. Nutrition Reviews 16(7): 222-223

McLORINAN, H. 1953: Measles (morbilli). Medical Journal of Australia 2(9): 348-349

Anonymous 1956: PHOSPHATE transfer in the digestive tract. Nutrition Reviews 14(6): 177-179

Anonymous 1960: PHOSPHATIDE-INDUCED hypercholesteremia. Nutrition Reviews 18: 219-221

Houston, B.; Stewart, A.J.; Farquharson, C. 2004: PHOSPHO1-A novel phosphatase specifically expressed at sites of mineralisation in bone and cartilage. Bone 34(4): 629-637

Anonymous 1951: PHOSPHOLIPID synthesis in patients with liver damage. Nutrition Reviews 9(8): 247-248

Anonymous 1951: PHOSPHORUS metabolism in brain. Nutrition Reviews 9(2): 58-59

Anonymous 1955: PHOSPHORUS requirements of the chicken. Nutrition Reviews 13(8): 234-235

Anonymous 1951: PHOTOCHEMICAL activity of riboflavin. Nutrition Reviews 9(3): 85-86

Aller, L.H. 1966: PHOTOELECTRIC SPECTROPHOTOMETRY OF eta CARINAE. Proceedings of the National Academy of Sciences of the United States of America 55(4): 671-676

Chao, T.P.; T'ien, C.Y. 1959: Improved apparatus for roentgenography for Meyer's positions. Zhonghua Fang she Xue Za Zhi Chinese Journal of Radiology 7(1): 69-70

Anonymous 1950: PHOTOGRAPHIC exposure computer. Review of Scientific Instruments 21(9): 819-820

Anonymous 1950: PHOTOGRAPHIC sensitisers. Manufacturing Chemist and Aerosol News 21(7): 296

Anonymous 1959: PHOTOGRAPHY implements research. Medical Radiography and Photography 35: 17

Korinth, D.; Donhuijsen, K.; Bockmühl, U.; Petersen, I. 2004: PHOTOPROBE biotin: an alternative method for labeling archival DNA for comparative genomic hybridization. Cellular Oncology: the Official Journal of the International Society for Cellular Oncology 26(5-6): 329-334